[{"text": "PREMIUM Sector Update: Health Care Stocks Softer Late Afternoon MT Newswires Wed, Jan 22, 2025, 11:52 PM 1 min read In This Article: ABT CLSD Health care stocks eased late Wednesday afternoon, with the NYSE Health Care Index and the Health Ca PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? Sign in Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "CLSD", "date": "2025-01-22T23:52:05", "sentiment": {"score": 0.04378141090273857, "confidence": 0.06611346453428268, "probabilities": {"positive": 0.06611346453428268, "negative": 0.022332053631544113, "neutral": 0.9115545153617859}}, "embedding": [-0.11708981543779373, -0.11150875687599182, 0.11633312702178955, 0.11694955825805664, 0.1837036907672882, -0.09455849230289459, 0.022780491039156914, -0.0030410559847950935, -0.04241315275430679, -0.06050370633602142, -0.0268365740776062, 0.15001219511032104, -0.11399756371974945, -0.12920859456062317, 0.071369968354702, 0.05111360922455788, 0.0643932968378067, -0.04677601158618927, -0.031891170889139175, 0.21376483142375946, -0.16124947369098663, 0.01852923445403576, 0.07114739716053009, 0.06896734237670898, 0.08678431808948517, 0.08309654891490936, 0.022292891517281532, -0.09026221930980682, 0.061149656772613525, -0.047701723873615265, -0.07755352556705475, -0.07274728268384933, 0.09094332158565521, -0.002472823252901435, -0.04180123656988144, 0.022537847980856895, 0.10614822804927826, 0.10282265394926071, 0.044831015169620514, 0.0952908918261528, 0.0921146348118782, -0.11296895146369934, -0.06993928551673889, 0.013877827674150467, 0.03810237720608711, -0.04135081544518471, -0.06272293627262115, -0.09747500717639923, 0.06724599003791809, 0.09569060057401657, 0.008904080837965012, -0.15877777338027954, -0.017955085262656212, -0.04499676078557968, -0.03162029758095741, -0.04312307387590408, -0.21261939406394958, -0.037379518151283264, -0.015095521695911884, -0.05324799194931984, -0.03766284137964249, -0.0803416296839714, 0.10674260556697845, 0.1821073591709137, -0.017767783254384995, 0.07724054157733917, 0.14414164423942566, 0.07222779840230942, -0.12033907324075699, -0.2503310739994049, -0.035141512751579285, -0.03165977820754051, -0.012625504285097122, -0.005996189545840025, 0.09740540385246277, 0.13499413430690765, 0.09706784039735794, -0.07779087126255035, 0.09823615849018097, -0.17974349856376648, 0.055069103837013245, -0.11359463632106781, 0.08318188786506653, 0.070626400411129, -0.06002549082040787, -0.026272766292095184, 0.07792305201292038, -0.15461356937885284, -0.06402096152305603, -0.2607334852218628, 0.22294054925441742, 0.001402492169290781, 0.02285461500287056, 0.01783869042992592, 0.018328959122300148, 0.033800527453422546, -0.11963383853435516, -0.08628629893064499, -0.27354007959365845, 0.07266349345445633, -0.02368980459868908, 0.15827415883541107, -0.026317395269870758, 0.08866746723651886, -0.10252160578966141, -0.20618082582950592, -0.010909737087786198, 0.09474256634712219, 0.06086631864309311, 0.11923624575138092, 0.015007308684289455, 0.1522856056690216, 0.009369351901113987, -0.17683595418930054, -0.21613255143165588, 0.09295802563428879, -0.14638957381248474, -0.05606065317988396, 0.07455865293741226, -0.00493039283901453, 0.013626809231936932, 0.07180767506361008, -0.27878621220588684, -0.054313402622938156, 0.029230715706944466, 0.15894576907157898, 0.023169828578829765, 1.2803647568997532e-32, 0.020722169429063797, 0.07326651364564896, 0.048739317804574966, -0.10920271277427673, -0.06395693123340607, -0.014874876476824284, 0.07832249999046326, -0.22579067945480347, -0.04755156859755516, -0.0877520740032196, -0.06241893768310547, 0.15743111073970795, 0.003719205502420664, -0.1104721650481224, -0.07533107697963715, -0.2117965817451477, -0.1377381533384323, 0.08507045358419418, 0.06435006111860275, 0.10077275335788727, -0.04964875429868698, -0.05073541775345802, -0.08108209073543549, -0.11394735425710678, -0.06352487951517105, -0.037771936506032944, 0.1353754699230194, -0.012496094219386578, 0.12316540628671646, 0.0859803855419159, -0.11953405290842056, 0.18042060732841492, -0.05805446207523346, -0.0956362783908844, 0.01819995976984501, 0.07600996643304825, -0.015923205763101578, -0.004986084531992674, 0.014717308804392815, -0.22156645357608795, -0.10035968571901321, -0.009517967700958252, -0.0652618482708931, -0.0753258690237999, 0.12454565614461899, 0.08435045927762985, 0.03813403099775314, -0.06454731523990631, 0.03816898539662361, -0.08791302144527435, -0.16634085774421692, 0.1836768239736557, -0.1400977075099945, 0.012003892101347446, -0.01402310561388731, -0.03368179500102997, 0.07451130449771881, -0.12619252502918243, -0.10128331184387207, 0.025368444621562958, 0.29550930857658386, 0.045093927532434464, 0.08968286961317062, -0.15513920783996582, -0.1541166454553604, 0.11073175817728043, -0.16983240842819214, 0.04027127847075462, -0.04441184550523758, 0.11920010298490524, 0.15299201011657715, 0.03227107971906662, 0.023135049268603325, -0.05570690333843231, -0.07520456612110138, 0.0014693710254505277, -0.012316190637648106, 0.03640185296535492, 0.02377849817276001, -0.014111303724348545, 0.11654241383075714, -0.03990313783288002, 0.14279545843601227, 0.1147601306438446, 0.16472724080085754, 0.036698002368211746, -0.015229918994009495, 0.07446569204330444, -0.04523984715342522, -0.10940338671207428, -0.1687365174293518, 0.059882812201976776, 0.08000808209180832, 0.13812178373336792, -0.15986484289169312, -1.4901499439664282e-32, -0.022577941417694092, -0.0064508444629609585, -0.06773325055837631, -0.008250248618423939, -0.02443789690732956, -0.06117447093129158, 0.07835270464420319, 0.11965872347354889, 0.14190630614757538, 0.1275104433298111, 0.09489864856004715, 0.05144111067056656, -0.14673782885074615, 0.02557504177093506, 0.09657113254070282, 0.10819205641746521, -0.10462955385446548, -0.09947177022695541, -0.08728569000959396, 0.16288819909095764, 0.06956200301647186, 0.09167199581861496, -0.01199382171034813, 0.3595583140850067, 0.1220436841249466, 0.07469280809164047, 0.004606218077242374, 0.20631790161132812, 0.09429159760475159, -0.1587986946105957, -0.1884472370147705, -0.0431443490087986, -0.1322241872549057, -0.009964125230908394, -0.13082671165466309, -0.08284144848585129, 0.09016270190477371, -0.023024629801511765, -0.15941311419010162, -0.09463925659656525, 0.051583584398031235, -0.14105474948883057, -0.08481968194246292, 0.08037484437227249, 0.15783682465553284, 0.07808073610067368, 0.06203177943825722, -0.07493023574352264, -0.027240078896284103, 0.017602581530809402, -0.04025156795978546, 0.04640311375260353, 0.07688068598508835, 0.2092946618795395, -0.13744553923606873, 0.12659397721290588, -0.13139589130878448, -0.04159395396709442, -0.22960051894187927, -0.12495231628417969, 0.010868064127862453, 0.238302543759346, -0.15051132440567017, -0.04384399950504303, -0.006479409523308277, -0.024612946435809135, 0.04967932030558586, -0.23037585616111755, -0.02127980999648571, -0.0806930810213089, -0.08885887265205383, -0.1462600827217102, -0.18203631043434143, -0.23743636906147003, 0.05337431654334068, 0.16676770150661469, 0.07280272245407104, -0.14399035274982452, -0.12737451493740082, 0.17279887199401855, 0.02430395968258381, -0.05318902060389519, -0.014070560224354267, 0.012684078887104988, -0.14998021721839905, 0.10232259333133698, 0.07539796084165573, -0.23502188920974731, -0.18268707394599915, 0.1266798973083496, -0.22905968129634857, -0.10888762027025223, -0.05367159843444824, 0.1369180828332901, -0.07017001509666443, -1.0010972317786582e-07, 0.08917447924613953, -0.09801561385393143, 0.014057081192731857, 0.014307815581560135, 0.0767313614487648, -0.1699487864971161, -0.20169928669929504, 0.003805514657869935, -0.0020555646624416113, 0.23493799567222595, -0.040823690593242645, 0.1216529905796051, -0.05512911453843117, 0.03234121575951576, -0.0035516584757715464, 0.022479457780718803, -0.16944989562034607, 0.16241207718849182, -0.031186701729893684, -0.17716628313064575, -0.03743394836783409, 0.03434176743030548, 0.27611789107322693, 0.04890727996826172, 0.024739006534218788, 0.09577866643667221, -0.04889392852783203, -0.03807227313518524, 0.1887550950050354, 0.07652615010738373, -0.06240174546837807, 0.035597287118434906, 0.11553262174129486, -0.005704652983695269, 0.035598024725914, 0.015866314992308617, 0.08352172374725342, 0.05584314838051796, 0.062200941145420074, 0.16532199084758759, 0.13330134749412537, -0.0439680740237236, 0.03238620609045029, 0.0648277997970581, 0.017105797305703163, -0.06464307010173798, -0.06891307234764099, -0.010772530920803547, 0.1835177093744278, -0.13356567919254303, 0.10683494061231613, -0.1847684234380722, 0.10790720582008362, 0.008993541821837425, -0.013711855746805668, 0.0971059501171112, -0.16089937090873718, -0.11649274080991745, -0.16552652418613434, 0.2910705506801605, 0.07434295117855072, -0.26462438702583313, 0.11511468887329102, 0.14304625988006592], "changes": {"1wk": -3.6649180348741477}}, {"text": "PREMIUM Clearside's Partner Receives NDA Approvals for Uveitic Macular Edema Treatment in Australia, Singapore MT Newswires Wed, Jan 22, 2025, 7:52 PM 1 min read In This Article: CLSD Clearside Biomedical (CLSD) said Wednesday its China-based partner, Arctic Vision, has received regu PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? Sign in Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "CLSD", "date": "2025-01-22T19:52:07", "sentiment": {"score": 0.07372855581343174, "confidence": 0.08424153178930283, "probabilities": {"positive": 0.08424153178930283, "negative": 0.010512975975871086, "neutral": 0.9052455425262451}}, "embedding": [-0.08130408078432083, -0.045849449932575226, 0.10790189355611801, -0.07807989418506622, 0.15955819189548492, -0.11862701922655106, 0.028987538069486618, -0.03965898975729942, -0.09607414901256561, 0.122894786298275, 0.13549970090389252, 0.03129331022500992, -0.04733476787805557, 0.06402146816253662, 0.11183153837919235, 0.0012042693560943007, -0.004054322838783264, -0.09222009778022766, -0.017410781234502792, 0.03909679129719734, -0.08691348880529404, 0.12770883738994598, 0.01593504287302494, -0.11291368305683136, -0.11529545485973358, 0.041442856192588806, 0.12138313800096512, -0.1497766077518463, 0.14829684793949127, -0.09066255390644073, -0.06253542751073837, 3.15338620566763e-05, 0.008413245901465416, -0.047099072486162186, 0.1684698760509491, -0.15988068282604218, -0.03743359073996544, -0.08845527470111847, -0.34467798471450806, 0.0963769182562828, -0.005663301795721054, -0.04926197603344917, -0.08470585942268372, 0.05147607624530792, 0.1630435287952423, -0.14326779544353485, -0.08825068920850754, -0.018725523725152016, 0.026680534705519676, 0.0640784278512001, 0.07260113954544067, -0.2430104911327362, -0.02492191083729267, -0.01641840487718582, -0.06861482560634613, 0.09555476158857346, -0.29379233717918396, -0.2316938191652298, -0.08869646489620209, -0.0900624692440033, -0.02855185978114605, -0.12359382212162018, -0.05056783929467201, 0.14852134883403778, -0.05690917745232582, 0.12246447801589966, -0.049810104072093964, -0.14077919721603394, 0.05473117157816887, -0.2529611885547638, -0.11985967308282852, -0.0719466432929039, 0.08345212787389755, 0.13308078050613403, -0.09737908840179443, 0.14008595049381256, 0.2606647312641144, -0.05148310214281082, 0.14869752526283264, -0.07401254773139954, 0.09224086254835129, 0.09064042568206787, 0.16632716357707977, 0.008611960336565971, 0.24990272521972656, -0.006627186667174101, 0.0023448956198990345, 0.057535141706466675, -0.03123771771788597, -0.18035300076007843, 0.1555304080247879, 0.030289072543382645, -0.009435904212296009, -0.010221373289823532, -0.08408480882644653, -0.08287752419710159, -0.11480984091758728, -0.08623644709587097, -0.22265151143074036, 0.07200249284505844, -0.12099380046129227, 0.041855327785015106, -0.13919655978679657, 0.047502800822257996, -0.12035763263702393, 0.03091326355934143, 0.14572466909885406, 0.12457431107759476, 0.0111851179972291, 0.15295206010341644, 0.03109116479754448, 0.06080034002661705, -0.002452076179906726, 0.039309725165367126, -0.13636626303195953, 0.17542676627635956, -0.041555821895599365, 0.0071988822892308235, 0.27633973956108093, -0.1760600060224533, -0.03456637263298035, -0.04740585759282112, -0.05353068932890892, -0.15339313447475433, 0.04521280527114868, 0.1335839480161667, 0.14329516887664795, 8.210952936768453e-33, -0.05381379649043083, 0.13191522657871246, 0.052178286015987396, -0.15784046053886414, 0.043721504509449005, 0.003408420830965042, -0.02813005819916725, -0.026790639385581017, -0.2050626128911972, -0.1916799396276474, -0.22513599693775177, 0.1865815371274948, -0.0018329122103750706, 0.26990583539009094, -0.08409295231103897, -0.14750875532627106, 0.05804101377725601, 0.31231167912483215, -0.03163457289338112, 0.15175604820251465, 0.02559044025838375, 0.10449765622615814, 0.12966518104076385, -0.041751205921173096, -0.17045822739601135, 0.1783096343278885, 0.05217265337705612, 0.022888509556651115, 0.4185327887535095, 0.0746975913643837, -0.15967385470867157, 0.0715826004743576, 0.026334863156080246, -0.03559384495019913, -0.028561359271407127, 0.2826777994632721, 0.11402708292007446, -0.034782517701387405, -0.04338948428630829, 0.08629727363586426, -0.035209354013204575, 0.21605044603347778, -0.17913857102394104, -0.21705582737922668, 0.028192289173603058, -0.07237838953733444, -0.173275426030159, 0.007321085315197706, 0.07583697140216827, -0.06988698244094849, -0.18471218645572662, 0.09605136513710022, -0.3114910423755646, -0.04649856686592102, 0.15615630149841309, 0.006904853507876396, -0.06597495824098587, 0.00147521891631186, 0.1016022115945816, -0.09648112952709198, 0.18027585744857788, -0.021131757646799088, -0.06783560663461685, -0.053124330937862396, 0.013400580734014511, 0.07171066105365753, 0.009545166045427322, -0.15862350165843964, -0.32232043147087097, -0.23906853795051575, 0.041307784616947174, 0.10655876249074936, -0.04946167394518852, 0.0475325733423233, 0.07354149222373962, -0.09232112020254135, -0.04721361771225929, 0.20919989049434662, 0.09474475681781769, 0.12423082441091537, -0.0023043937981128693, 0.08648891746997833, 0.09882516413927078, -0.055982768535614014, 0.09007541835308075, 0.0038285821210592985, -0.05528195947408676, 0.22421607375144958, -0.07738928496837616, -0.09187467396259308, 0.12736335396766663, 0.011167535558342934, -0.09101506322622299, 0.08823401480913162, -0.08094430714845657, -8.77502198253419e-33, -0.11550088971853256, -0.13034456968307495, -0.1257992684841156, -0.011074685491621494, 0.00348669639788568, 0.03801817074418068, 0.05247645080089569, 0.07828366756439209, 0.17140920460224152, -0.12820670008659363, 0.12051225453615189, 0.04615340009331703, -0.07137937843799591, -0.07151277363300323, 0.02232201397418976, -0.010257618501782417, 0.020525366067886353, 0.025715604424476624, -0.2210060954093933, 0.02376607619225979, 0.13694532215595245, -0.0012991848634555936, 0.08927277475595474, 0.12044083327054977, 0.1000605896115303, 0.08469482511281967, 0.17128057777881622, 0.18341676890850067, -0.12882396578788757, -0.1599092334508896, -0.10041837394237518, 0.11433901637792587, -0.2975824475288391, 0.07023777812719345, -0.04882969334721565, 0.0040223849937319756, -0.15291030704975128, 0.09663712978363037, -0.11837948113679886, 0.12642145156860352, -0.011430894955992699, -0.13056893646717072, -0.09631215780973434, 0.03864865005016327, 0.0223749540746212, -0.0791635736823082, -0.15802571177482605, -0.0044978102669119835, 0.025247298181056976, -0.04597076401114464, -0.11382783949375153, 0.07445045560598373, 0.10164947062730789, 0.09644114971160889, -0.15516246855258942, 0.08850063383579254, 0.052601657807826996, 0.08562741428613663, 0.08553296327590942, -0.03258505091071129, 0.1515427827835083, 0.07323960959911346, -0.1711703985929489, -0.055159635841846466, 0.17118225991725922, 0.18675073981285095, 0.14524392783641815, 0.03738730028271675, 0.028150586411356926, -0.05794980004429817, -0.02351616695523262, -0.1996692270040512, -0.2971639931201935, -0.13140340149402618, 0.12942038476467133, 0.11463696509599686, 0.038535818457603455, -0.04039604961872101, -0.09819384664297104, 0.12609751522541046, -0.004130278714001179, -0.14532063901424408, 0.055625367909669876, 0.3467906415462494, -0.06500981748104095, 0.06599144637584686, 0.11152327060699463, -0.34375235438346863, -0.04031561315059662, 0.16919200122356415, -0.3060622215270996, -0.12101604044437408, -0.33294323086738586, 0.12338631600141525, -0.030193954706192017, -9.974856141070632e-08, 0.01166251115500927, -0.15538717806339264, -0.009784547612071037, 0.010330785065889359, -0.1523553729057312, -0.07267802208662033, -0.1487668752670288, 0.09131763130426407, -0.017086243256926537, -0.07148096710443497, 0.0417989082634449, 0.13239751756191254, 0.01310904510319233, -0.006547494791448116, 0.06676319986581802, 0.11114063858985901, 0.2512010633945465, 0.24310874938964844, -0.03764570131897926, -0.16799914836883545, -0.1452517956495285, 0.05543796718120575, 0.2439533770084381, -0.112810879945755, -0.0962860956788063, 0.2193228304386139, -0.0016408775700256228, 0.1317872554063797, 0.06490594893693924, -0.14082683622837067, 0.05976811423897743, 0.022874290123581886, 0.22948840260505676, 0.08290212601423264, -0.05516861751675606, -0.08729555457830429, 0.2084086388349533, 0.09434165805578232, 0.149389386177063, 0.11495139449834824, -0.07028224319219589, 0.007949179969727993, 0.10263852030038834, -0.010451259091496468, -0.01215406320989132, -0.046944547444581985, 0.09458211809396744, -0.08069247752428055, -0.057359859347343445, -0.04738499969244003, -0.05667401850223541, -0.20436447858810425, -0.01998271979391575, 0.043680135160684586, -0.3146164119243622, -0.009678782895207405, 0.06588540971279144, -0.21815696358680725, -0.16701926290988922, 0.21541239321231842, 0.09866774827241898, -0.1932901293039322, 0.09217627346515656, 0.16846610605716705], "changes": {"1wk": -3.6649180348741477}}, {"text": "Clearside Biomedical Announces its Asia-Pacific Partner, Arctic Vision, Received Approval of Suprachoroidal Treatment for Uveitic Macular Edema in Australia and Singapore Clearside Biomedical, Inc. Wed, Jan 22, 2025, 3:05 PM 6 min read In This Article: CLSD Clearside Biomedical, Inc. - ARCATUS \u00ae , Branded as XIPERE \u00ae in the U.S., is the First Globally Approved Suprachoroidal Therapy - - Continued Global Expansion of Clearside\u2019s Suprachoroidal Space Injection Platform Featuring its Commercially Proven SCS Microinjector \u00ae - ALPHARETTA, Ga., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc.\u00a0(Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS \u00ae ), announced today that Arctic Vision\u2019s new drug applications for ARCATUS \u00ae (triamcinolone acetonide 4 mg/0.1 mL injection suspension vial kit) have been approved by the Therapeutic Goods Administration of Australia and the Health Sciences Authority in Singapore for the treatment of uveitic macular edema (UME). George Lasezkay, PharmD, JD, President and Chief Executive Officer of Clearside, commented, \u201cWe congratulate our partner, Arctic Vision, for the outstanding progress advancing our product in the Asia-Pacific region. These global regulatory approvals confirm that our innovative SCS delivery platform enables the treatment of patients with sight-threatening eye diseases. We expect that retinal specialists across the world will use this in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of potential therapies.\u201d Arctic Vision is a China-based ophthalmic biotech that has the exclusive license for the commercialization and development of XIPERE \u00ae , which they refer to as ARCATUS \u00ae or ARVN001, in Greater China, South Korea, Australia, New Zealand, India and the ASEAN Countries. In July 2024, Arctic Vision announced positive topline results from its Phase 3 UME clinical trial in China. In November 2024, Arctic Vision signed a commercial collaboration agreement granting rights to Santen Pharmaceutical Co., Ltd. to commercialize ARVN001 for the treatment of UME and certain other ophthalmic indications under development in China, excluding Taiwan, Hong Kong and Macau. In addition, Arctic Vision is developing ARVN001 for other ocular retinal diseases, including diabetic macular edema. About Clearside\u2019s Suprachoroidal Space (SCS \u00ae ) Injection Platform and SCS Microinjector \u00ae Clearside\u2019s patent protected, proprietary suprachoroidal space (SCS \u00ae ) injection treatment approach offers unprecedented access to the back of the eye, where sight-threatening disease often occurs. The Company\u2019s unique platform is inherently flexible and intended to work with established and new formulations of medications. Clearside\u2019s patented SCS Microinjector \u00ae can deliver a wide variety of drug candidates into the suprachoroidal space, providing targeted delivery to potentially improve efficacy and compartmentalization of medication to reduce or eliminate toxic effects on non-diseased cells. The SCS Microinjector is comprised of a syringe with a custom-designed hub and two 30-gauge hollow microneedles of varying lengths, each approximately one millimeter, optimizing insertion and suprachoroidal administration of drugs. Story Continues About XIPERE \u00ae (triamcinolone acetonide injectable suspension) for suprachoroidal use XIPERE \u00ae (triamcinolone acetonide injectable suspension) for suprachoroidal use is a proprietary suspension of the corticosteroid triamcinolone acetonide for administration to the suprachoroidal space for the treatment of macular edema associated with uveitis. XIPERE is approved by the U.S. Food and Drug Administration and is commercially available in the United States. Bausch + Lomb, a leading global eye health company dedicated to helping people see better to live better, has the exclusive license for the commercialization and development of XIPERE in the U.S. and Canada. Arctic Vision, a China-based ophthalmic biotech, has the exclusive license for the commercialization and development of XIPERE, which they refer to as ARCATUS \u00ae or ARVN001, in Greater China, South Korea, Australia, New Zealand, India and the ASEAN Countries. About Uveitis and Macular Edema Uveitis is a set of ocular inflammatory conditions and is one of the leading causes of vision loss, affecting approximately 350,000 patients in\u00a0the United States\u00a0and more than one million worldwide. Approximately one-third of these patients develop uveitic macular edema, a build-up of fluid in the macula, the area of the retina responsible for sharp, straight-ahead vision. Macular edema is the leading cause of vision loss and blindness in uveitis patients and can occur from uveitis affecting any anatomic location - anterior, intermediate, posterior or pan. The global uveitis treatment market is projected to grow from approximately $2.3 billion in 2023 to $4.5 billion by 2032. 1 Source: 1 Gotadki, Rahul, Market Research Future, Uveitis Treatment Market Research Report by Treatment Type , January 2025. About Clearside Biomedical, Inc. Clearside Biomedical, Inc. is a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS \u00ae ) to improve patient outcomes. Clearside\u2019s SCS injection platform, utilizing the Company\u2019s patented SCS Microinjector \u00ae , enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases. Clearside is developing its own pipeline of small molecule product candidates for administration via its SCS Microinjector. The Company\u2019s lead program, CLS-AX (axitinib injectable suspension) , for the treatment of neovascular age-related macular degeneration (wet AMD), recently completed a Phase 2b clinical trial, and planning for a Phase 3 program is underway. Clearside developed and gained approval for its first product, XIPERE \u00ae (triamcinolone acetonide injectable suspension) for suprachoroidal use, which is available in the U.S. through a commercial partner. Clearside also strategically partners its SCS injection platform with companies utilizing other ophthalmic therapeutic innovations. For more information, please visit clearsidebio.com or follow us on LinkedIn and X . Cautionary Note Regarding Forward-Looking Statements Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements may be identified by words such as \u201cbelieve\u201d, \u201cexpect\u201d, \u201cmay\u201d, \u201cplan\u201d, \u201cpotential\u201d, \u201cwill\u201d, and similar expressions, and are based on Clearside\u2019s current beliefs and expectations. These forward-looking statements include statements regarding the potential benefits of Clearside\u2019s suprachoroidal delivery technology and Clearside\u2019s SCS Microinjector \u00ae . These statements involve risks and uncertainties that could cause actual results to differ materially from those reflected in such statements. Risks and uncertainties that may cause actual results to differ materially include uncertainties inherent in the conduct of clinical trials, Clearside\u2019s reliance on third parties over which it may not always have full control and other risks and uncertainties that are described in Clearside\u2019s Annual Report on Form 10-K for the year ended December 31, 2023, filed with the U.S. Securities and Exchange Commission (SEC) on March 12, 2024, Clearside\u2019s Quarterly Report on Form 10-Q for the quarter ended September 30, 2024, filed with the SEC on November 12, 2024, and Clearside\u2019s other periodic reports filed with the SEC. Any forward-looking statements speak only as of the date of this press release and are based on information available to Clearside as of the date of this release, and Clearside assumes no obligation to, and does not intend to, update any forward-looking statements, whether as a result of new information, future events or otherwise. Source: Clearside Biomedical, Inc. CONTACT: Investor and Media Contacts: Jenny Kobin Remy Bernarda ir@clearsidebio.com (678) 430-8206 View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "CLSD", "date": "2025-01-22T15:05:00", "sentiment": {"score": 0.7022921415045857, "confidence": 0.7101526260375977, "probabilities": {"positive": 0.7101526260375977, "negative": 0.007860484533011913, "neutral": 0.28198689222335815}}, "embedding": [-0.05254106968641281, -0.1320727914571762, -0.03679800406098366, -0.09712041914463043, 0.06658528745174408, -0.1454612761735916, 0.08272910118103027, 0.1567125916481018, 0.04203673079609871, 0.1716957688331604, -0.00042185187339782715, 0.01926995813846588, 0.031380657106637955, 0.1009136438369751, -0.04131939262151718, 0.058869436383247375, -0.01771431788802147, 0.0061889225617051125, -0.033296890556812286, 0.0681065022945404, 0.12224076688289642, 0.011765699833631516, -0.08947794139385223, -0.007504445035010576, -0.21761752665042877, 0.07744631916284561, 0.015568610280752182, -0.11749481409788132, -0.1310940533876419, -0.09210699796676636, -0.07790963351726532, 0.06179308891296387, -0.08748454600572586, 0.01482242252677679, 0.04768747463822365, 0.0013195537030696869, -0.1422901302576065, -0.08647970855236053, -0.17302311956882477, 0.06519146263599396, -0.01744840294122696, -0.021039729937911034, -0.1465790867805481, -0.012894835323095322, 0.13206394016742706, -0.09862355142831802, -0.11455746740102768, -0.02649093046784401, -0.03341079503297806, 0.14001065492630005, -0.03481059521436691, -0.1560051143169403, -0.07657107710838318, 0.04792775213718414, -0.14101961255073547, 0.06453640758991241, -0.20625907182693481, -0.15454429388046265, 0.0016484670341014862, -0.004128953441977501, -0.025699231773614883, -0.15491700172424316, -0.0076913656666874886, 0.06744331866502762, -0.0040293848142027855, 0.032502494752407074, 0.03233851119875908, -0.20308397710323334, 0.05401762202382088, -0.10212886333465576, 0.011528708040714264, -0.04768742620944977, 0.008659448474645615, 0.2150464802980423, -0.15470363199710846, 0.07781714200973511, 0.2788904905319214, 0.0627589151263237, 0.14665701985359192, -0.06325729191303253, 0.23227044939994812, 0.18219691514968872, 0.08793163299560547, 0.026275381445884705, 0.16626256704330444, 0.14009690284729004, 0.04059029370546341, 0.06112714484333992, 0.06271560490131378, 0.02103840932250023, 0.11273375153541565, 0.006090214475989342, 0.007084614131599665, -0.08172138035297394, -0.06478375196456909, -0.12208764255046844, 0.0016054394654929638, 0.031090211123228073, -0.11360986530780792, -0.008534819819033146, -0.01581665687263012, -0.06971682608127594, -0.13522404432296753, -0.08301471173763275, -0.07937923073768616, -0.028172485530376434, 0.15408718585968018, -0.06030484288930893, 0.02131921797990799, 0.04410085454583168, -0.13557110726833344, 0.04560038447380066, -0.029429694637656212, -0.0034801578149199486, -0.11599020659923553, 0.2637902796268463, -0.0021885232999920845, 0.0022902097553014755, 0.2691935896873474, -0.08336949348449707, -0.00015996582806110382, 0.03336986154317856, 0.07550888508558273, -0.10774201154708862, 0.09520740807056427, 0.08476953208446503, 0.07231974601745605, 9.976877528857636e-33, -0.09706932306289673, 0.09102478623390198, -0.03664880990982056, -0.039094146341085434, -0.0019926289096474648, -0.06932834535837173, 0.03827287629246712, 0.1203208938241005, -0.25291913747787476, -0.1313372403383255, -0.23958155512809753, 0.05686898157000542, -0.01691538281738758, 0.28514838218688965, 0.014580892398953438, -0.09938611090183258, 0.10143273323774338, 0.17771942913532257, -0.10409978777170181, -0.01964925229549408, -0.007819810882210732, 0.10024342685937881, 0.08360695093870163, 0.09383729100227356, -0.10199801623821259, 0.13886457681655884, -0.10283701121807098, 0.05848323926329613, 0.12663733959197998, 0.058416858315467834, -0.12764468789100647, 0.08407317101955414, 0.0693369135260582, -0.01679196022450924, -0.06629123538732529, 0.05257948487997055, 0.008516700938344002, -0.0863901674747467, 0.03829217329621315, 0.13323307037353516, 0.0818999782204628, 0.22415223717689514, -0.1468350887298584, -0.06486840546131134, 0.0884781926870346, -0.04037245362997055, -0.12375738471746445, 0.12483806163072586, -0.03738037124276161, -0.02739330567419529, -0.11967910826206207, 0.05909012630581856, -0.049932025372982025, -0.08984553068876266, 0.04014965891838074, 0.0908336192369461, -0.14151939749717712, -0.027438903227448463, 0.09563478827476501, -0.008434968069195747, -0.0038615772500634193, -0.009326708503067493, -0.045741867274045944, 0.10936945676803589, 0.023921910673379898, 0.08848293125629425, 0.07549427449703217, -0.09076080471277237, -0.19797027111053467, -0.1137794703245163, -0.014795932918787003, -0.010505489073693752, 0.16304412484169006, 0.06200554221868515, 0.20078426599502563, -0.03725475072860718, 0.01730281487107277, 0.22716493904590607, -0.022328533232212067, 0.01562979817390442, -0.11926700174808502, 0.10987219214439392, -0.002249206881970167, 0.03734223544597626, -0.006105814129114151, -0.00493333674967289, 0.04813121259212494, 0.1286294311285019, -0.14250001311302185, -0.05565320700407028, 0.14984267950057983, -0.07321722060441971, -0.0836196020245552, 0.01793672889471054, -0.06393630057573318, -7.18325569472696e-33, -0.0891822800040245, -0.08273930847644806, -0.13293954730033875, 0.013781281188130379, -0.07433509826660156, 0.18266978859901428, 0.1333509385585785, -0.05588633567094803, 0.08755459636449814, -0.13444188237190247, 0.11846393346786499, 0.02054295502603054, 0.005945390090346336, -0.05701076239347458, -0.08437839150428772, 0.03163251653313637, -0.01701122149825096, 0.010290388949215412, -0.1558714061975479, 0.027836475521326065, 0.15276700258255005, 0.07318367063999176, 0.02293803170323372, -0.04067488759756088, 0.07739473879337311, 0.09098716825246811, 0.20104405283927917, 0.11492535471916199, 0.03998291492462158, -0.07768754661083221, -0.09717011451721191, 0.10141841322183609, -0.20189203321933746, 0.05044941231608391, -0.09073379635810852, 0.053306929767131805, -0.0656367689371109, -0.07146741449832916, -0.1451876014471054, -0.005963328294456005, -0.025111498311161995, -0.08124326169490814, -0.06364185363054276, 0.056947048753499985, 0.037473246455192566, -0.03902484104037285, 0.004897437058389187, 0.020822186022996902, 0.12736430764198303, -0.047600481659173965, -0.1675133854150772, -0.03389093652367592, 0.001273052766919136, 0.03114016354084015, -0.12387855350971222, -0.028782417997717857, -0.05542530119419098, -0.037802234292030334, 0.026268061250448227, -0.05428574979305267, 0.09744631499052048, 0.019844677299261093, -0.009102169424295425, -0.051516372710466385, 0.13526077568531036, 0.1574968844652176, 0.11228922009468079, 0.09939466416835785, 0.02833670750260353, -0.14358748495578766, 0.005229550413787365, -0.13171547651290894, -0.0761246383190155, -0.04114123806357384, 0.07799521088600159, 0.0514831617474556, 0.10805890709161758, -0.12852241098880768, -0.09889484941959381, 0.013558249920606613, -0.00832013227045536, -0.09568066149950027, -0.023894164711236954, 0.2573421597480774, 0.03209937363862991, 0.1266733705997467, 0.0662224292755127, -0.14937017858028412, -0.0626499280333519, 0.06484111398458481, -0.18565033376216888, -0.06739699840545654, -0.25296247005462646, 0.164471834897995, 0.005328013561666012, -1.0011184770064574e-07, 0.17726856470108032, -0.07417938113212585, 0.0032124780118465424, 0.00728612020611763, -0.12118582427501678, -0.06563012301921844, -0.09401562064886093, 0.06512769311666489, -0.039682962000370026, -0.06816685944795609, -0.055957138538360596, 0.21873968839645386, 0.009994547814130783, 0.021398786455392838, 0.012957234866917133, 0.057756099849939346, 0.033232804387807846, 0.17984989285469055, -0.0575479194521904, -0.06556933373212814, -0.17833212018013, 0.0011012284085154533, 0.12372434139251709, -0.1170671135187149, 0.0136136244982481, 0.08860358595848083, -0.014959264546632767, 0.08906269818544388, -0.01676682010293007, -0.11045827716588974, 0.02503724955022335, -0.01793309487402439, 0.1724100261926651, 0.15502101182937622, -0.013256562873721123, -0.12291618436574936, -0.027755528688430786, 0.1715404987335205, 0.13176557421684265, 0.1262717992067337, -0.0724250003695488, 0.09801028668880463, 0.03235559165477753, 0.050250306725502014, -0.06693094223737717, -0.03975165635347366, 0.025279179215431213, -0.08806891739368439, 0.0187652800232172, 0.011934153735637665, -0.13097348809242249, -0.06146877259016037, -0.03637175261974335, -0.05008433014154434, -0.17359116673469543, 0.012701651081442833, 0.06317055225372314, -0.21174223721027374, -0.09318628907203674, 0.0901331901550293, 0.03844364359974861, -0.11996674537658691, 0.08926914632320404, 0.09686450660228729], "changes": {"1wk": -3.6649180348741477}}, {"text": "Clearside announces publication of insights on drug development, regulation TipRanks Fri, Dec 20, 2024, 3:16 PM 1 min read In This Article: CLSD https://www.tipranks.com/news/the-fly/intuitive-surgical-court-win-similar-to-class-action-suit-says-wells-fargo Clearside Biomedical ( CLSD ) announced that the official journal of The Royal College of Ophthalmologists, Eye, published a summary of critical insights into drug development and regulatory processes based on a presentation at the prestigious annual Edridge Green Lecture by Clearside\u2019s Chief Medical Officer and Executive Vice President, Head of Research and Development, Dr. Victor Chong. The article, which was published in December 2024 by Eye and Nature.com, provides a comprehensive overview of the intricate processes involved in clinical trial design and regulatory pathways for drug development, with a special focus on retinal diseases. Pick the best stocks and maximize your portfolio: Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks Published first on TheFly \u2013 the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on CLSD: Clearside Biomedical Highlights Advancements in Drug Delivery Clearside extends global footprint with presentations at medical meetings Clearside Biomedical Reports Positive Q3 2024 Results Clearside Biomedical reports Q3 EPS (10c), consensus (12c) CLSD Earnings Report this Week: Is It a Buy, Ahead of Earnings? View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "CLSD", "date": "2024-12-20T15:16:19", "sentiment": {"score": 0.13437077309936285, "confidence": 0.1454421430826187, "probabilities": {"positive": 0.1454421430826187, "negative": 0.011071369983255863, "neutral": 0.843486487865448}}, "embedding": [-0.05696569010615349, -0.13425993919372559, -0.03199493885040283, -0.06760868430137634, 0.045722655951976776, 0.0022993674501776695, 0.11089476943016052, 0.17837832868099213, 0.028360066935420036, 0.16186097264289856, -0.08457513898611069, 0.18605920672416687, -0.10085855424404144, 0.08348816633224487, -0.16256895661354065, 0.10684698075056076, 0.029047410935163498, -0.02726428024470806, -0.08099441230297089, 0.03835735470056534, 0.03633729740977287, -0.07443400472402573, 0.12094991654157639, -0.0081245182082057, -0.12189767509698868, 0.05685728043317795, -0.043866485357284546, -0.13165059685707092, -0.074950210750103, -0.120584636926651, -0.03559165447950363, 0.05183150991797447, 0.037591323256492615, -0.09101439267396927, -0.11653575301170349, -0.017782576382160187, -0.07352545112371445, 0.06046300753951073, 0.10444587469100952, 0.10764342546463013, 0.006475124973803759, -0.09026966243982315, -0.16461920738220215, 0.03908439353108406, 0.09008034318685532, -0.2037801891565323, -0.012595954351127148, 0.02199620194733143, -0.02313011698424816, 0.04768877476453781, -0.17144474387168884, -0.17045265436172485, -0.003324648132547736, 0.050213612616062164, -0.06912802159786224, 0.04597242549061775, -0.24995674192905426, -0.09254197776317596, -0.007418027147650719, -0.0377139188349247, -0.021656641736626625, -0.037168897688388824, 0.04140423983335495, 0.05505870655179024, 0.022381780669093132, 0.012901430949568748, -0.046943675726652145, -0.023160770535469055, 0.010707554407417774, -0.09363473206758499, -0.004857234191149473, -0.07483217865228653, 0.053152408450841904, 0.021431712433695793, -0.057806480675935745, 0.1002432256937027, 0.16440297663211823, 0.1358468383550644, 0.09482761472463608, -0.11290568113327026, 0.14715835452079773, 0.027646461501717567, 0.028816061094403267, 0.08362880349159241, 0.05972886458039284, 0.014523058198392391, 0.05674276500940323, 0.026348568499088287, -0.002345565939322114, -0.006154537200927734, 0.17058880627155304, -0.005668883677572012, -0.0430205799639225, -0.06446443498134613, 0.00878619309514761, 0.00941553059965372, -0.13126340508460999, -0.04719574749469757, -0.009600799530744553, 0.03284028545022011, -0.01803065463900566, 0.06339287757873535, -0.0967889353632927, -0.129465252161026, -0.09363111853599548, -0.02202705480158329, 0.17912974953651428, 0.015677187591791153, -0.015312276780605316, 0.010321348905563354, -0.015939930453896523, 0.12975016236305237, 0.0005774019518867135, 0.06361903250217438, -0.005716349929571152, 0.22914700210094452, -0.07257435470819473, 0.036552634090185165, 0.3013889789581299, -0.038900211453437805, 0.02170414663851261, 0.001976859522983432, 0.021391205489635468, -0.09121791273355484, 0.015523421578109264, 0.1995118111371994, -0.1355067640542984, 9.098086768390525e-33, 0.014936030842363834, 0.06676647067070007, -0.010988053865730762, 0.03161216154694557, -0.024123823270201683, 0.009991282597184181, 0.05933445692062378, -0.10985565930604935, -0.23159247636795044, -0.011918731965124607, -0.11891716718673706, -0.028213294222950935, -0.052875932306051254, 0.1417110115289688, -0.056550804525613785, -0.13050159811973572, -0.025483066216111183, 0.09476852416992188, -0.02546951174736023, -0.11085796356201172, -0.023366285488009453, -0.0438632033765316, -0.0733969509601593, -0.05824130028486252, -0.025172777473926544, 0.03842950239777565, -0.08242855966091156, -0.021248361095786095, 0.0914621502161026, 0.06500285863876343, -0.06896550953388214, 0.13520470261573792, 0.043425533920526505, -0.09620194137096405, -0.025321470573544502, 0.06054113805294037, -0.04041435942053795, -0.10783164203166962, 0.06575032323598862, 0.0677584633231163, -0.07154490798711777, 0.15524017810821533, -0.10665474832057953, -0.18712559342384338, 0.02105996571481228, -0.004002936650067568, -0.1775856763124466, 0.11423459649085999, 0.025144366547465324, -0.07984273135662079, -0.0889914408326149, -0.016690446063876152, 0.009003950282931328, -0.13337548077106476, 0.004243278875946999, 0.053715456277132034, -0.14382481575012207, -0.08212682604789734, -0.044761426746845245, 0.03565544635057449, 0.07328241318464279, 0.21348558366298676, -0.12884624302387238, -0.0006109786918386817, -0.12146864086389542, 0.07822314649820328, -0.04582652822136879, 0.023859871551394463, -0.09012693166732788, 0.009644297882914543, 0.03348241373896599, 0.04851311072707176, 0.05889156833291054, 0.000888738373760134, 0.09673663228750229, -0.033711109310388565, 0.017112918198108673, 0.10051832348108292, -0.0008936187950894237, 0.010961652733385563, 0.09714547544717789, -0.0011821967782452703, -0.015412380918860435, 0.11393801122903824, 0.02792339026927948, -0.10586380958557129, 0.059524089097976685, 0.06077694147825241, -0.07357259839773178, -0.01894284226000309, -0.05075397714972496, -0.03539222106337547, 0.012908444739878178, 0.09745233505964279, -0.14429828524589539, -8.678818790178924e-33, -0.10641363263130188, -0.050671420991420746, 0.04100949689745903, -0.007826371118426323, 0.009166519157588482, 0.05605533719062805, 0.06209031492471695, -0.05470259487628937, 0.14155004918575287, -0.10693949460983276, 0.011756235733628273, 0.09822031110525131, -0.04763896018266678, -0.06980403512716293, -0.06791989505290985, -0.020497510209679604, -0.1097031831741333, -0.09051192551851273, -0.12923786044120789, -0.03454025462269783, 0.07176004350185394, 0.06576067209243774, -0.023026812821626663, 0.10837052017450333, 0.07556213438510895, 0.14510948956012726, 0.06165379285812378, 0.15891335904598236, -0.06452944874763489, -0.007686116266995668, -0.08231864124536514, 0.029303373768925667, -0.14203789830207825, 0.049774158746004105, -0.09860412776470184, 0.05563045293092728, 0.008327508345246315, -0.245732843875885, 0.03417568281292915, 0.02582736127078533, 0.05086144432425499, -0.06314323842525482, 0.029682721942663193, -0.028882840648293495, 0.060626447200775146, -0.014631558209657669, -0.048999566584825516, 0.1614210456609726, 0.04682627692818642, -0.0013054670998826623, -0.08923450857400894, 0.08643597364425659, 0.04533426836133003, 0.04614140838384628, -0.08731438964605331, 0.024212602525949478, 0.015982922166585922, -0.0005956399836577475, -0.016236988827586174, 0.008809243328869343, 0.006565820891410112, 0.1251905858516693, -0.08862311393022537, 0.059391558170318604, 0.05023336037993431, -0.02631606161594391, 0.08172052353620529, 0.048643335700035095, -0.013119908049702644, -0.1387816220521927, 0.002301927888765931, -0.13952603936195374, -0.03178899362683296, -0.09905461221933365, 0.09351803362369537, 0.16905666887760162, -0.019023746252059937, -0.135079026222229, -0.1015889048576355, 0.1733720451593399, 0.03999485448002815, -0.08816912025213242, -0.02346331812441349, 0.12476569414138794, 0.059883177280426025, 0.18789760768413544, 0.026245029643177986, -0.11453745514154434, -0.025393253192305565, 0.009414189495146275, -0.1580534428358078, -0.22037319839000702, -0.14398211240768433, 0.1286565363407135, 0.0182954128831625, -9.998890959650453e-08, 0.12472306936979294, -0.13109681010246277, 0.057166606187820435, -0.035660650581121445, -0.06171463057398796, -0.03944092616438866, -0.06680119782686234, 0.04010338708758354, -0.09404740482568741, 0.05675078183412552, 0.01611456647515297, 0.15036877989768982, -0.11914811283349991, 0.03171856701374054, 0.07868003100156784, -0.009471099823713303, -0.04350479692220688, 0.08009322732686996, -0.08917268365621567, -0.13571400940418243, -0.05234645679593086, -0.01119033619761467, 0.13711778819561005, 0.07478882372379303, 0.08988130837678909, -0.02287420816719532, -0.00803049374371767, -0.003343473421409726, 0.0049846540205180645, 0.04442648962140083, 0.07416221499443054, 0.07791410386562347, 0.23154276609420776, 0.017002727836370468, 0.06237034499645233, -0.0020959656685590744, 0.06174342706799507, 0.06576788425445557, 0.06483815610408783, 0.2132018506526947, -0.0634695440530777, 0.043768610805273056, 0.04577863961458206, -0.004307473544031382, 0.02316093258559704, -0.1274913251399994, -0.0009488813229836524, 0.04853576421737671, 0.03978528827428818, -0.08841008692979813, 0.028312459588050842, -0.15810458362102509, 0.0554756224155426, -0.013170409947633743, -0.10600779205560684, 0.09080151468515396, -0.07470910996198654, 0.020409079268574715, -0.06995218247175217, -0.13594479858875275, 0.13933385908603668, -0.01856040582060814, 0.12052600830793381, 0.1220650002360344], "changes": {"1wk": 6.651379533131571, "1mo": 6.651379533131571}}, {"text": "Clearside Biomedical, Inc. (CLSD) Reports Q3 Loss, Tops Revenue Estimates Zacks Equity Research Wed, Nov 13, 2024, 2:05 AM 3 min read In This Article: CLSD Clearside Biomedical, Inc. (CLSD) came out with a quarterly loss of $0.10 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to loss of $0.15 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 28.57%. A quarter ago, it was expected that this company would post a loss of $0.14 per share when it actually produced a loss of $0.10, delivering a surprise of 28.57%. Over the last four quarters, the company has surpassed consensus EPS estimates three times. Clearside Biomedical , which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $1.04 million for the quarter ended September 2024, surpassing the Zacks Consensus Estimate by 310.28%. This compares to year-ago revenues of $0.86 million. The company has topped consensus revenue estimates two times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Clearside Biomedical shares have lost about 6.8% since the beginning of the year versus the S&P 500's gain of 25.8%. What's Next for Clearside Biomedical? While Clearside Biomedical has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for Clearside Biomedical: mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is -$0.14 on $0.25 million in revenues for the coming quarter and -$0.56 on $0.83 million in revenues for the current fiscal year. Story Continues Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical - Biomedical and Genetics is currently in the top 29% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1. Medtronic (MDT), another stock in the broader Zacks Medical sector, has yet to report results for the quarter ended October 2024. The results are expected to be released on November 19. This medical device company is expected to post quarterly earnings of $1.24 per share in its upcoming report, which represents a year-over-year change of -0.8%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. Medtronic's revenues are expected to be $8.26 billion, up 3.5% from the year-ago quarter. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Clearside Biomedical, Inc. (CLSD) : Free Stock Analysis Report Medtronic PLC (MDT) : Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "CLSD", "date": "2024-11-13T02:05:20", "sentiment": {"score": -0.4573805406689644, "confidence": 0.5538264513015747, "probabilities": {"positive": 0.09644591063261032, "negative": 0.5538264513015747, "neutral": 0.3497276306152344}}, "embedding": [-0.11523076891899109, -0.029183806851506233, 0.04300623759627342, -0.01300782524049282, -0.04839698225259781, -0.08555254340171814, 0.01209239661693573, 0.11565488576889038, 0.20809680223464966, 0.09758133441209793, -0.08532411605119705, 0.06171663850545883, -0.03264384716749191, -0.042567022144794464, -0.11100530624389648, 0.049383170902729034, 0.013006443157792091, 0.02691173180937767, -0.12149064242839813, 0.10178320109844208, -0.05607694387435913, 0.06166451796889305, 0.09025280177593231, 0.03942253813147545, 0.014080334454774857, 0.0723905861377716, -0.05972786247730255, -0.002382539212703705, -0.09874497354030609, -0.1318938434123993, -0.053818248212337494, 0.11134006828069687, 0.12317021191120148, -0.10575437545776367, -0.08919250965118408, -0.03711410611867905, -0.05329577624797821, 0.06653758883476257, 0.12541645765304565, 0.017764862626791, -0.0653163269162178, 0.050379592925310135, -0.13551586866378784, -0.006186877377331257, -0.060461901128292084, -0.18084654211997986, -0.030635327100753784, -0.028150616213679314, 0.06665882468223572, 0.07736251503229141, -0.10218946635723114, -0.14198718965053558, 0.07966525107622147, 0.13423922657966614, -0.15878036618232727, 0.03620612248778343, -0.21270060539245605, -0.12330777943134308, -0.030933640897274017, 0.01434312853962183, -0.017213638871908188, 0.009632918052375317, 0.050645746290683746, 0.10971163213253021, 0.17576521635055542, 0.008188242092728615, 0.02051469124853611, 0.01459602639079094, -0.10304652154445648, -0.019543923437595367, 0.08332601189613342, -0.08199400454759598, -0.05391991138458252, 0.002159843221306801, -0.09811873733997345, 0.11789654195308685, 0.17755377292633057, 0.2064642310142517, 0.08964328467845917, -0.09163694083690643, 0.043901070952415466, -0.0366993211209774, -0.06571744382381439, -0.029016945511102676, 0.01412473525851965, 0.05651281774044037, 0.17610839009284973, 0.13520348072052002, -0.051986850798130035, 0.01551176980137825, 0.012374227866530418, -0.027043821290135384, 0.047839876264333725, -0.07142598927021027, 0.026773378252983093, 0.07209520041942596, -0.09582480788230896, -0.06103532761335373, 0.046700261533260345, 0.06262226402759552, 0.07320791482925415, 0.2002965807914734, -0.0977923572063446, -0.1564795970916748, -0.02996828593313694, -0.10569426417350769, 0.13982564210891724, -0.02548953890800476, -0.007283080369234085, 0.057133711874485016, 0.012699592858552933, 0.09608566761016846, -0.10849986970424652, 0.010869169607758522, -0.020534470677375793, 0.13142210245132446, -0.00456186942756176, 0.14801561832427979, 0.18350514769554138, 0.0649372935295105, 0.020864542573690414, 0.013292568735778332, -0.04016983509063721, -0.018522046506404877, -0.05431516468524933, 0.17303872108459473, -0.08703351020812988, 5.8276058143816176e-33, 0.07352665066719055, 0.03220726549625397, 0.015411728993058205, -0.09881129860877991, -0.0366816446185112, -0.014663844369351864, 0.010266099125146866, -0.047913968563079834, -0.0784081518650055, -0.0793546587228775, -0.11116854846477509, 0.10363596677780151, -0.012368552386760712, -0.07543343305587769, 0.024844111874699593, -0.11036582291126251, -0.08143424987792969, 0.08499187231063843, 0.018970394507050514, -0.05852644145488739, 0.00277659110724926, 0.0005705393850803375, -0.04040044918656349, 0.020856980234384537, 0.02339879795908928, -0.009094416163861752, -0.09287428855895996, 0.022276801988482475, -0.043096985667943954, 0.04259626194834709, -0.05008196458220482, 0.05066809803247452, 0.09088060259819031, -0.17856353521347046, -0.10577674955129623, 0.011858578771352768, -0.006792551837861538, 0.007750319316983223, 0.12234453856945038, 0.12236535549163818, -0.09644882380962372, 0.08169287443161011, -0.15616720914840698, -0.25830763578414917, -0.02308422327041626, -0.02856694720685482, -0.046554237604141235, 0.02458105981349945, 0.035502418875694275, -0.04713030904531479, -0.05910332873463631, -0.007669385522603989, 0.0006986819207668304, -0.031198685988783836, 0.0011772150173783302, 0.029219195246696472, -0.02635769546031952, -0.17132818698883057, -0.03694659098982811, 0.17558051645755768, 0.1613233983516693, 0.27698153257369995, 0.02124704234302044, -0.06507238000631332, -0.21685191988945007, 0.18557795882225037, 0.027482349425554276, 0.09553785622119904, -0.13079342246055603, 0.1308336704969406, -0.024490492418408394, -0.03729056194424629, 0.042637456208467484, -0.03404479846358299, 0.1892031878232956, -0.07220102846622467, -0.03939742594957352, -0.03722133859992027, 0.07212238758802414, 0.060143113136291504, 0.07935309410095215, -0.0037818043492734432, -0.07925829291343689, 0.021738529205322266, 0.048893433064222336, -0.006085714790970087, 0.053732678294181824, 0.09718295931816101, -0.06664137542247772, -0.04402833431959152, 0.002313301432877779, -0.07435794174671173, -0.04336289316415787, 0.1487669050693512, -0.09286582469940186, -6.1403299233705634e-33, -0.10251808166503906, 0.027105003595352173, -0.05657714605331421, 0.04492481052875519, -0.036117322742938995, -0.01487508974969387, 0.12671293318271637, 0.10528015345335007, 0.004187841899693012, -0.03786667436361313, -0.001543467864394188, 0.10134616494178772, -0.17429959774017334, 0.02986663579940796, -0.03434418886899948, 0.02283770963549614, 0.0191950760781765, -0.13347654044628143, -0.042825013399124146, -0.06405484676361084, 0.08353684842586517, 0.1720520257949829, -0.026127450168132782, 0.12508416175842285, 0.0893787294626236, 0.1018383800983429, -0.04855208098888397, 0.29285067319869995, 0.05179859325289726, -0.09921407699584961, -0.0005360916256904602, -0.04436894506216049, -0.10352258384227753, 0.016509363427758217, 0.018192917108535767, -0.0665053129196167, -0.006469803862273693, -0.16306433081626892, 0.03154643997550011, -0.056046612560749054, 0.06757919490337372, 0.008578900247812271, 0.0035464316606521606, 0.030612215399742126, 0.0841626226902008, -0.00867009349167347, -0.052970901131629944, 0.0435941219329834, 0.17482709884643555, 0.061165060847997665, -0.011249260976910591, 0.05605274811387062, -0.05478933826088905, 0.18539723753929138, -0.13992634415626526, 0.05482664704322815, -0.13530009984970093, 0.007489307783544064, -0.10975423455238342, -0.003679464105516672, -0.0396152026951313, 0.14330601692199707, -0.04992342367768288, 0.1028699278831482, 0.046636953949928284, 0.002959683770313859, 0.03588017076253891, -0.017196930944919586, -0.1110343188047409, -0.08381898701190948, -0.03050655499100685, -0.10151898860931396, 0.05261891335248947, -0.15451538562774658, 0.09699343144893646, 0.28964999318122864, -0.02621009573340416, -0.24693551659584045, -0.061224475502967834, 0.07897021621465683, 0.01066836342215538, 0.019184499979019165, 0.042170703411102295, 0.003599564079195261, -0.09594133496284485, 0.18758872151374817, -0.03858576714992523, -0.12512634694576263, -0.033520687371492386, 0.03379148617386818, -0.1093904972076416, -0.22473551332950592, -0.15057790279388428, 0.042348988354206085, 0.010721631348133087, -9.951740764790884e-08, 0.11628514528274536, -0.1437881886959076, 0.06302254647016525, -0.02011709287762642, 0.029045632109045982, -0.06943533569574356, -0.01378767378628254, -0.017070459201931953, 0.062411561608314514, 0.042807649821043015, 0.06125127151608467, 0.048210509121418, -0.2010410875082016, 0.057324714958667755, -0.10929931700229645, 0.10654684901237488, -0.08612479269504547, 0.026789674535393715, -0.017517205327749252, -0.2186495065689087, -0.08765149116516113, 0.003707190975546837, 0.14745140075683594, -0.04341137409210205, 0.08470162749290466, -0.06193152815103531, -0.07527631521224976, -0.024056505411863327, 0.006356123834848404, -0.04498943313956261, 0.1078231930732727, -0.017611879855394363, 0.16851255297660828, 0.121993288397789, 0.010190305300056934, -0.08662872761487961, 0.05111682415008545, 0.06495187431573868, 0.045201703906059265, 0.20567013323307037, 0.014607292599976063, -0.01632634736597538, -0.004218749701976776, -0.01515345461666584, 0.010582691058516502, -0.1399046927690506, -0.08037570118904114, 0.0780729204416275, -0.01619931310415268, -0.2541990876197815, 0.11829181015491486, -0.1389966756105423, 0.050114601850509644, 0.0974162220954895, 0.05333255976438522, 0.03954297676682472, -0.18914613127708435, 0.0024461019784212112, -0.17154622077941895, -0.00912879966199398, 0.06650260835886002, -0.20007580518722534, 0.0951562449336052, 0.13069671392440796], "changes": {"1wk": -7.207210980571571, "1mo": -9.9099110709451}}, {"text": "Clearside Biomedical Announces Publication of Critical Insights into Retinal Drug Development in the Peer-Reviewed Scientific Journal, Eye Clearside Biomedical, Inc. Thu, Dec 19, 2024, 3:05 PM 3 min read In This Article: CLSD Clearside Biomedical, Inc. ALPHARETTA, Ga., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc.\u00a0(Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS \u00ae ), announced today that the official journal of The Royal College of Ophthalmologists, Eye , published a summary of critical insights into drug development and regulatory processes based on a presentation at the prestigious annual Edridge Green Lecture by Clearside\u2019s Chief Medical Officer and Executive Vice President, Head of Research and Development, Dr. Victor Chong. The article, which was published in December 2024 by Eye and Nature.com , provides a comprehensive overview of the intricate processes involved in clinical trial design and regulatory pathways for drug development, with a special focus on retinal diseases. Dr. Chong's lecture focused on the structure of clinical trials, crucial efficacy and safety endpoints, and the expectations of regulatory agencies like the U.S. Food & Drug Administration. Key recent advancements, such as incorporating low-luminance vision as a secondary endpoint, and case studies from age-related macular degeneration trials, highlight the evolving landscape of drug approvals. The lecture also examined the dynamic landscape of geographic atrophy and diabetic retinopathy trials, emphasizing new anatomical endpoints and innovative drugs. Dr. Chong stressed the value of academic-industry collaborations, citing examples in gene therapy development and novel endpoint measures for retinal dystrophies. Victor Chong, M.D., MBA, commented, \u201cAs a long-time clinician and researcher, it was an honor to be selected to give the Edridge Green Lecture. By highlighting recent advancements, case studies, and regulatory expectations, we can help accelerate the process of finding treatments and cures for serious retinal diseases.\u201d The Edridge Green Lecture is highly significant in the field of ophthalmology and visual sciences and has been delivered at the Royal College of Ophthalmologists Annual Congress since 1956. The Lecture plays a vital role in educating and inspiring the next generation of clinicians and researchers, ultimately contributing to better patient care and outcomes in ophthalmology. The full publication can be accessed here . About Clearside Biomedical, Inc. Clearside Biomedical, Inc. is a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS \u00ae ) to improve patient outcomes. Clearside\u2019s SCS injection platform, utilizing the Company\u2019s patented SCS Microinjector \u00ae , enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases. Clearside is developing its own pipeline of small molecule product candidates for administration via its SCS Microinjector. The Company\u2019s lead program, CLS-AX (axitinib injectable suspension) , for the treatment of neovascular age-related macular degeneration (wet AMD), recently completed a Phase 2b clinical trial, and planning for a Phase 3 program is underway. Clearside developed and gained approval for its first product, XIPERE \u00ae (triamcinolone acetonide injectable suspension) for suprachoroidal use, which is available in the U.S. through a commercial partner. Clearside also strategically partners its SCS injection platform with companies utilizing other ophthalmic therapeutic innovations. For more information, please visit clearsidebio.com or follow us on LinkedIn and X . Story Continues Investor and Media Contacts: Jenny Kobin Remy Bernarda ir@clearsidebio.com Source: Clearside Biomedical, Inc. View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "CLSD", "date": "2024-12-19T15:05:00", "sentiment": {"score": 0.29533347953110933, "confidence": 0.30454742908477783, "probabilities": {"positive": 0.30454742908477783, "negative": 0.009213949553668499, "neutral": 0.6862386465072632}}, "embedding": [-0.05201154202222824, -0.18843460083007812, 0.004391990602016449, 0.014020159840583801, -0.009789565578103065, -0.11468417942523956, 0.008986903354525566, 0.19656404852867126, 0.09267478436231613, 0.16462087631225586, -0.04105319827795029, 0.07691344618797302, -0.03188628703355789, 0.013538366183638573, -0.13439011573791504, 0.06903991103172302, -0.08768333494663239, 0.05749835819005966, -0.08473140001296997, 0.08486133068799973, 0.20842480659484863, -0.020936939865350723, 0.03859253600239754, 0.08114732801914215, -0.22485379874706268, 0.03582805395126343, -0.016169976443052292, -0.12793326377868652, -0.1950269341468811, -0.08889079093933105, -0.009251929819583893, 0.11667381972074509, -0.013653881847858429, 0.008646736852824688, 0.02661553956568241, 0.08017091453075409, -0.07824324816465378, 0.02695220708847046, -0.12518619000911713, 0.03597626835107803, -0.11267312616109848, 0.018427973613142967, -0.19301334023475647, 0.12988285720348358, 0.13325491547584534, -0.25183749198913574, -0.06366639584302902, 0.07493501901626587, -0.10186859965324402, 0.10138197243213654, -0.13949017226696014, -0.1300053894519806, -0.03994198888540268, -0.06493119895458221, -0.0355239138007164, 0.09411504864692688, -0.23343104124069214, -0.07085631042718887, 0.05992653965950012, 0.010960434563457966, -0.02897227555513382, -0.1023407131433487, -0.0030327020213007927, -0.07654422521591187, -0.030000265687704086, -0.027091074734926224, 0.06254957616329193, -0.12001219391822815, 0.00466217240318656, -0.115715391933918, -0.024053670465946198, -0.06788326054811478, 0.08560901135206223, 0.0766364336013794, -0.05749651789665222, 0.047266725450754166, 0.12359444051980972, 0.09691062569618225, 0.0419265478849411, -0.11687958985567093, 0.2790253162384033, 0.07953743636608124, 0.10124678909778595, 0.03354209288954735, 0.10628221929073334, 0.0682324767112732, -0.04173210263252258, 0.04489300027489662, 0.03455963358283043, -0.001100238529033959, 0.1316116452217102, 0.038366734981536865, -0.12650632858276367, -0.01648663729429245, -0.012251406908035278, -0.05692843347787857, -0.04375103861093521, -0.06142956763505936, 0.02189132384955883, 0.04848162829875946, -0.05301128327846527, -0.00497199734672904, -0.04569495469331741, -0.10593828558921814, -0.11162624508142471, -0.06463433802127838, 0.17399483919143677, -0.0038762567564845085, -0.022978343069553375, 0.03328314051032066, 0.053287774324417114, 0.07621252536773682, -0.045908257365226746, 0.11188755929470062, -0.04346387833356857, 0.1591178923845291, -0.03359765559434891, -0.056919313967227936, 0.30608075857162476, -0.12006990611553192, 0.05192536860704422, 0.02920784428715706, 0.08544394373893738, -0.11675246059894562, 0.045564621686935425, 0.0979602038860321, -0.004731022287160158, 4.447644139467378e-33, -0.021905388683080673, 0.07578495144844055, 0.01390458270907402, 0.07543088495731354, 0.06681794673204422, -0.04972480982542038, 0.051069557666778564, 0.05676432326436043, -0.2865254878997803, -0.09347499907016754, -0.18328236043453217, -0.01349148340523243, -0.021044299006462097, 0.19633698463439941, 0.009349597617983818, -0.11306977272033691, 0.017028430476784706, 0.08346330374479294, 0.014051712118089199, -0.11333366483449936, -0.15215525031089783, 0.023303907364606857, -0.0403752401471138, -0.05041297525167465, -0.09856805205345154, 0.08679069578647614, -0.08078750967979431, 0.04632743448019028, 0.1303865909576416, 0.05652124807238579, -0.05150143429636955, 0.14105382561683655, 0.15148618817329407, -0.1404857188463211, 0.010185914114117622, 0.03909574821591377, 0.056294988840818405, -0.05953620374202728, 0.01960883103311062, 0.059144504368305206, -0.03577848896384239, 0.17338073253631592, -0.10435651242733002, -0.12071399390697479, 0.07512305676937103, 0.07650932669639587, -0.020751994103193283, 0.15563106536865234, -0.034789759665727615, 0.03226850926876068, 0.002193646738305688, -0.07694166153669357, 0.020314304158091545, -0.2019045650959015, -0.06818994134664536, 0.11589691042900085, -0.20689436793327332, -0.06556388735771179, 0.02886718139052391, 0.0357406921684742, 0.03551669046282768, 0.15192052721977234, -0.08110949397087097, 0.08341725915670395, -0.02085377834737301, -0.026639007031917572, -0.011748025193810463, -0.012412434443831444, -0.1663476526737213, -0.06368528306484222, -0.019102593883872032, -0.062258511781692505, 0.10058720409870148, 0.0185262281447649, 0.11358287930488586, 0.033737409859895706, 0.01824050024151802, 0.2377496063709259, -0.021472761407494545, 0.002659478224813938, 0.012511354871094227, 0.06819092482328415, -0.1454072892665863, 0.07500732690095901, 0.03606272488832474, -0.018899135291576385, 0.07755904644727707, 0.10504283756017685, -0.04515007883310318, -0.003504460444673896, 0.12524639070034027, -0.08858662098646164, -0.04554164782166481, 0.042304567992687225, -0.015285419300198555, -6.912967666486668e-33, -0.08225864171981812, -0.06488408148288727, -0.010475224815309048, 0.015040170401334763, -0.03796087205410004, 0.14485526084899902, 0.05480986833572388, -0.10913072526454926, 0.24261368811130524, -0.2614470422267914, 0.012453459203243256, 0.04387646168470383, -0.0465615838766098, -0.04691369831562042, -0.10270877182483673, 0.10147731751203537, -0.10357081890106201, 0.012609729543328285, -0.21846717596054077, 0.05170685797929764, 0.028980083763599396, 0.04870281368494034, 0.030977196991443634, -0.0790720134973526, 0.10608038306236267, 0.11524029076099396, 0.18620459735393524, 0.09846808761358261, -0.08516638725996017, -0.009345730766654015, -0.007095145061612129, 0.05962594971060753, -0.21729600429534912, -0.014239479787647724, -0.08830996602773666, 0.042900316417217255, -0.11518789827823639, -0.17782413959503174, -0.07245173305273056, -0.005489496514201164, 0.06724903732538223, -0.016506126150488853, 0.007573854178190231, -0.08248671889305115, 0.06151610240340233, 0.00292937271296978, 0.031106628477573395, 0.059332817792892456, 0.056507520377635956, -0.03610745444893837, -0.08835606276988983, 0.04440951347351074, 0.018307292833924294, -0.04558510705828667, -0.07571079581975937, -0.025239359587430954, 0.03877676650881767, 0.029450174421072006, 0.04094557464122772, 0.026949968189001083, 0.028176965191960335, -0.03515912592411041, -0.08920561522245407, 0.04602649807929993, 0.12984219193458557, 0.013529399409890175, 0.15642133355140686, 0.06013045087456703, 0.1358620822429657, -0.10670716315507889, 0.007648432161659002, -0.12112616747617722, -0.1335778832435608, -0.04536871612071991, 0.03256019204854965, 0.09519597887992859, -0.050723154097795486, -0.0656033605337143, -0.18474987149238586, 0.1508365422487259, 0.032760147005319595, -0.08148663491010666, -0.09451626241207123, 0.20809635519981384, 0.007550771813839674, 0.10875003039836884, 0.07199860364198685, -0.03468824177980423, 0.048156872391700745, 0.031738270074129105, -0.15592017769813538, -0.1714758276939392, -0.17604780197143555, 0.1514040231704712, -0.016271930187940598, -1.0019851970355376e-07, 0.16598999500274658, -0.055033955723047256, 0.027532432228326797, -0.07903984189033508, -0.06509092450141907, -0.07471294701099396, -0.012787064537405968, 0.1126062273979187, -0.11946815252304077, 0.10244154930114746, -0.06418436020612717, 0.23405590653419495, -0.08884009718894958, 0.08010397851467133, 0.022171832621097565, 0.06688381731510162, -0.005461200140416622, 0.07263554632663727, -0.038865938782691956, 0.05103414133191109, -0.09958934783935547, -0.05391029268503189, 0.03768336400389671, 0.0010659703984856606, 0.02080274373292923, -0.03117806278169155, 0.01193998847156763, 0.021144231781363487, -0.04202994704246521, -0.0900440439581871, 0.1911681592464447, 0.06627875566482544, 0.14838983118534088, 0.019520539790391922, -0.036270029842853546, -0.20804864168167114, -0.03456878289580345, 0.11837291717529297, 0.0849548727273941, 0.1970977783203125, -0.1354767084121704, 0.019856030121445656, 0.056416288018226624, 0.0699385553598404, -0.08257842063903809, -0.0637364611029625, 0.054209962487220764, 0.08503594994544983, 0.014778942801058292, -0.004900092724710703, -0.09761230647563934, -0.0904945582151413, 0.024140527471899986, -0.13072851300239563, -0.22476470470428467, -0.0468965545296669, 0.02882516011595726, -0.0367044061422348, -0.09036405384540558, -0.22247204184532166, 0.117032989859581, 0.03527548164129257, 0.05478566139936447, 0.06736000627279282], "changes": {"1wk": -0.10752549652751674, "1mo": 0.0}}, {"text": "Here's Why Clearside Biomedical (CLSD) Is a Great 'Buy the Bottom' Stock Now Zacks Equity Research Thu, Dec 12, 2024, 5:55 PM 3 min read In This Article: CLSD Shares of Clearside Biomedical, Inc. (CLSD) have been struggling lately and have lost 5.6% over the past two weeks. However, a hammer chart pattern was formed in its last trading session, which could mean that the stock found support with bulls being able to counteract the bears. So, it could witness a trend reversal down the road. While the formation of a hammer pattern is a technical indication of nearing a bottom with potential exhaustion of selling pressure, rising optimism among Wall Street analysts about the future earnings of this company is a solid fundamental factor that enhances the prospects of a trend reversal for the stock. 1-month candlestick chart for CLSD Understanding Hammer Chart and the Technique to Trade It This is one of the popular price patterns in candlestick charting. A minor difference between the opening and closing prices forms a small candle body, and a higher difference between the low of the day and the open or close forms a long lower wick (or vertical line). The length of the lower wick being at least twice the length of the real body, the candle resembles a 'hammer.' In simple terms, during a downtrend, with bears having absolute control, a stock usually opens lower compared to the previous day's close, and again closes lower. On the day the hammer pattern is formed, maintaining the downtrend, the stock makes a new low. However, after eventually finding support at the low of the day, some amount of buying interest emerges, pushing the stock up to close the session near or slightly above its opening price. When it occurs at the bottom of a downtrend, this pattern signals that the bears might have lost control over the price. And, the success of bulls in stopping the price from falling further indicates a potential trend reversal. Hammer candles can occur on any timeframe -- such as one-minute, daily, weekly -- and are utilized by both short-term as well as long-term investors. Like every technical indicator, the hammer chart pattern has its limitations. Particularly, as the strength of a hammer depends on its placement on the chart, it should always be used in conjunction with other bullish indicators. Here's What Makes the Trend Reversal More Likely for CLSD An upward trend in earnings estimate revisions that CLSD has been witnessing lately can certainly be considered a bullish indicator on the fundamental side. That's because empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements. Over the last 30 days, the consensus EPS estimate for the current year has increased 14%. What it means is that the sell-side analysts covering CLSD are majorly in agreement that the company will report better earnings than they predicted earlier. Story Continues If this is not enough, you should note that CLSD currently has a Zacks Rank #2 (Buy), which means it is in the top 20% of more than the 4,000 stocks that we rank based on trends in earnings estimate revisions and EPS surprises. And stocks carrying a Zacks Rank #1 or 2 usually outperform the market. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Moreover, a Zacks Rank of 2 for Clearside Biomedical is a more conclusive indication of a potential trend reversal, as the Zacks Rank has proven to be an excellent timing indicator that helps investors identify precisely when a company's prospects are beginning to improve. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Clearside Biomedical, Inc. (CLSD) : Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "CLSD", "date": "2024-12-12T17:55:05", "sentiment": {"score": -0.5676814131438732, "confidence": 0.6113414168357849, "probabilities": {"positive": 0.0436600036919117, "negative": 0.6113414168357849, "neutral": 0.3449985682964325}}, "embedding": [-0.12059806287288666, -0.048034653067588806, 0.14416557550430298, 0.0013405121862888336, -8.163973689079285e-05, -0.08482438325881958, -0.01174420677125454, 0.08652004599571228, 0.19462773203849792, 0.08162783086299896, -0.06695416569709778, 0.15108990669250488, -0.045900940895080566, -0.115288645029068, -0.016240760684013367, 0.04650168493390083, -0.07393451780080795, -0.12634506821632385, -0.1344791054725647, 0.09545719623565674, 0.017273785546422005, -0.08334723860025406, -0.07542005181312561, 0.015326462686061859, -0.1262819468975067, 0.08676958084106445, -0.06947880983352661, 0.008555592969059944, 0.09574706107378006, -0.015724902972579002, -0.023903120309114456, 0.14296583831310272, 0.018681947141885757, -0.01576533168554306, -0.17816561460494995, 0.01687362976372242, 0.021007653325796127, 0.13072988390922546, 0.11916741728782654, 0.1062140166759491, -0.013871540315449238, 0.006243598647415638, -0.101272813975811, -0.05328765884041786, -0.037406064569950104, -0.034963835030794144, -0.04185444861650467, -0.06792843341827393, -0.06399344652891159, 0.02411487326025963, -0.0053963568061590195, -0.07680916041135788, 0.008886083960533142, 0.11237230896949768, -0.05022718012332916, 0.041170135140419006, -0.09600522369146347, -0.03971736133098602, 0.10033266246318817, 0.008657666854560375, 0.048270534723997116, 0.09001611173152924, -0.07015518844127655, 0.06734861433506012, 0.23151257634162903, -0.033309176564216614, 0.011936892755329609, -0.019829608500003815, 0.03679952770471573, 0.06895454972982407, 0.1377665400505066, -0.05892518162727356, -0.07617785036563873, -0.02584271878004074, 0.039737507700920105, 0.07754472643136978, 0.15555661916732788, 0.04574023187160492, 0.015485165640711784, -0.15134590864181519, -0.08854149281978607, 0.01920073665678501, 0.009718735702335835, -0.013274898752570152, -0.002798495115712285, 0.0026198308914899826, 0.0915856808423996, -0.061377570033073425, 0.03531581908464432, 0.07932679355144501, 0.0816846489906311, -0.09930294752120972, -0.11966437101364136, 0.00944558810442686, 0.043384768068790436, 0.04149352386593819, 0.0169124286621809, 0.11853590607643127, 0.017597975209355354, 0.10548867285251617, 0.0331791415810585, 0.10632657259702682, -0.061084404587745667, -0.09362286329269409, -0.017854006960988045, -0.12828560173511505, 0.011694299057126045, 0.017913294956088066, -0.08271165192127228, 0.0076722754165530205, -0.03381166234612465, 0.05960870906710625, 0.04100363329052925, 0.012998860329389572, -0.09226000308990479, 0.005141709931194782, -0.09877075254917145, -0.015848737210035324, 0.03934668377041817, -0.03379451856017113, 0.10440605878829956, 0.023941144347190857, -0.11149642616510391, -0.07251158356666565, -0.09141123294830322, 0.13534221053123474, -0.06501894444227219, 5.543182833914672e-33, -0.021161619573831558, -0.061267443001270294, -0.05817442387342453, -0.1694013476371765, -0.09715263545513153, -0.0288594551384449, -0.11242088675498962, -0.05272648483514786, -0.04079735651612282, 0.17568404972553253, 0.07072815299034119, 0.20415356755256653, 0.06598443537950516, -0.009085185825824738, -0.025304367765784264, -0.11250484734773636, 0.036882851272821426, 0.0377623587846756, 0.02330729551613331, -0.1294880360364914, -0.07680096477270126, 0.008198696188628674, -0.06452721357345581, -0.10457288473844528, -0.08153113722801208, 0.057881321758031845, 0.033667851239442825, 0.020733505487442017, -0.08382979035377502, 0.06971850246191025, 0.049922652542591095, 0.11327117681503296, 0.015193967148661613, -0.12030240893363953, 0.011043679900467396, 0.02821597084403038, 0.06287727504968643, -0.10272087156772614, -0.009862367063760757, -0.09600512683391571, -0.07356677949428558, 0.013866596855223179, -0.2218710482120514, -0.09569855034351349, 0.008300934918224812, -0.03193296119570732, -0.04467296972870827, -0.034256868064403534, -0.07983671873807907, 0.010912742465734482, -0.058704353868961334, 0.06678679585456848, 0.04826575517654419, -0.029775019735097885, -0.007845604792237282, 0.03351239114999771, 0.06418067216873169, -0.18743079900741577, -0.09276458621025085, 0.04539624601602554, 0.10960763692855835, 0.13187725841999054, 0.04505840688943863, -0.03565407544374466, -0.10566636919975281, 0.050900377333164215, -0.056745339184999466, 0.060162272304296494, -0.10956531763076782, 0.07314930856227875, 0.026487136259675026, 0.06860974431037903, -0.0324106365442276, -0.10152438282966614, 0.062050797045230865, -0.05463575944304466, 0.05028625205159187, 0.09852726012468338, -0.028905238956212997, 0.03828487917780876, -0.038732293993234634, -0.09036596119403839, 0.04031268134713173, 0.01140456460416317, -0.02462128922343254, -0.08556263893842697, 0.006024321541190147, -0.055647172033786774, -0.21839940547943115, -0.07951487600803375, -0.039041973650455475, -0.028942380100488663, -0.03150743618607521, 0.19398286938667297, -0.0645037442445755, -6.610224973904142e-33, -0.09272630512714386, -0.01967013254761696, -0.06270074844360352, 0.07749472558498383, 0.03321986272931099, 0.07247070968151093, 0.08062943816184998, -0.04097473621368408, -0.1318548023700714, -0.01060563325881958, 0.02137114480137825, 0.04804478585720062, -0.17847013473510742, -0.005776120815426111, 0.013203166425228119, -0.024654405191540718, 0.058325059711933136, 0.012185702100396156, -0.03562268614768982, -0.08949267864227295, 0.09635204076766968, 0.20484383404254913, -0.13642683625221252, 0.08434190601110458, -0.00996831152588129, 0.07973316311836243, -0.046411797404289246, 0.1347830444574356, -0.05865521728992462, -0.047726571559906006, -0.0015157582238316536, -0.028920363634824753, -0.024004746228456497, -0.009523381479084492, -0.1226036548614502, 0.05236167088150978, 0.07325614988803864, -0.10738351941108704, 0.012615320272743702, -0.0027072899974882603, 0.0679575577378273, 0.05041681230068207, 0.1335562765598297, -0.10869240760803223, 0.0047281295992434025, 0.043274201452732086, 0.02647440694272518, 0.09671427309513092, 0.13551214337348938, 0.09468936920166016, 0.13687250018119812, 0.09130722284317017, -0.003313184715807438, 0.1317516714334488, -0.14057761430740356, 0.09512437880039215, -0.08311189711093903, -0.031038660556077957, -0.0940016582608223, 0.04640787094831467, 0.0021031645592302084, 0.07131078839302063, 0.05733766406774521, 0.05547264218330383, -0.005939103662967682, -0.09268598258495331, 0.02063954994082451, -0.10630808770656586, -0.06072760000824928, -0.09617990255355835, -0.008903048932552338, 0.07253076136112213, 0.04739797115325928, -0.07197703421115875, 0.04317380487918854, 0.08585134148597717, 0.037025026977062225, -0.23971810936927795, -0.030976608395576477, 0.037991710007190704, -0.18610897660255432, 0.032553158700466156, 0.06352951377630234, 0.1672178953886032, -0.13231933116912842, 0.10232283174991608, -0.20393142104148865, 0.032172489911317825, -0.05376272648572922, -0.008855298161506653, -0.027588563039898872, -0.09635184705257416, -0.1458979994058609, 0.005355276167392731, -0.01275758258998394, -9.95435911477216e-08, -0.004144410602748394, -0.13237422704696655, 0.011187849566340446, 0.03715530037879944, 0.028658974915742874, -0.0015992829576134682, 0.11596745252609253, 0.02273164875805378, -0.0650593489408493, 0.0555897131562233, 0.17975550889968872, 0.0879332423210144, -0.1180548444390297, 0.005740371532738209, -0.03497075289487839, 0.05632941052317619, -0.055946797132492065, -0.05053449422121048, -0.04268429055809975, -0.18093493580818176, 0.021841231733560562, -0.11105053126811981, 0.1565130352973938, 0.08561189472675323, 0.06675223261117935, -0.04993028938770294, -0.029688574373722076, 0.10930928587913513, -0.02449779212474823, 0.016537610441446304, 0.03709182143211365, 0.07425667345523834, 0.16496604681015015, -0.02742115780711174, 0.1224704384803772, 0.13484370708465576, 0.007240353152155876, 0.019917920231819153, -0.011681869626045227, 0.22972232103347778, -0.006513503380119801, 0.014333678409457207, -0.026391394436359406, 0.03717228025197983, 0.0636059120297432, -0.04265613481402397, 0.03265358507633209, 0.19320711493492126, 0.009648708626627922, -0.09743386507034302, 0.020261075347661972, -0.09014491736888885, 0.0832689106464386, 0.03279697522521019, 0.030216693878173828, 0.025598064064979553, -0.05673149600625038, -0.00955530907958746, -0.01608986034989357, 0.05212150141596794, 0.1212950050830841, -0.10633456707000732, -0.023189276456832886, 0.05406054109334946], "changes": {"1wk": -6.999999284744263, "1mo": -1.9999980926513672}}, {"text": "Analyst Sees 500% Upside for This Pharmaceutical Penny Stock Nauman khan Fri, Dec 20, 2024, 1:29 PM 1 Minuten Lesezeit In diesem Artikel: CLSD Clearside Biomedical, Inc. ( CLSD , Financial ), a biopharmaceutical company focused on innovative ophthalmic disease therapies, is drawing the attention of Wall Street as analysts see substantial upside potential for the company. On Thursday, shares closed at $0.93, down 4.12%, in a 52-week range of $0.92 to $2.12. The consensus average price target is $6.00 , and the potential upside is over 500%. Warning! GuruFocus has detected 3 Warning Signs with CLSD. The SCS Microinjector is Clearside's proprietary technology that enables the delivery of treatments to the back of the eye through the suprachoroidal space (SCS). Pivotal to developing its leading pipeline asset, CLS-AX, the platform that facilitates in-office and repeatable procedures, has been a key enabler. Now undergoing Phase 2b clinical trial completion Phase 3 planning for the treatment of neovascular age-related macular degeneration (wet AMD), this axitinib injectable suspension has been specifically developed. XIPERE, Clearside's first FDA-approved product for suprachoroidal injections, is commercially available through a partner in the US. Together, Clearside's strategic partnerships extend the use of its SCS injection platform for further therapeutic discoveries focused on the retina and choroid. Nevertheless, the stock holds six analysts with strong buy ratings, for a score of 4.83 over the past three months. Clearside is investing more time and money into expanding its commercialization efforts and is closely monitored by investors as the company plans its next phase of clinical trials. This article first appeared on GuruFocus . Kommentare anzeigen AGB und Datenschutzerkl\u00e4rung Privacy Dashboard Empfohlene Nachrichtenartikel", "symbol": "CLSD", "date": "2024-12-20T13:29:38", "sentiment": {"score": -0.0355190634727478, "confidence": 0.3717484474182129, "probabilities": {"positive": 0.3362293839454651, "negative": 0.3717484474182129, "neutral": 0.2920221984386444}}, "embedding": [-0.08030715584754944, -0.12150361388921738, -0.07605140656232834, -0.09604158252477646, 0.014060970395803452, -0.1265813261270523, 0.05145563185214996, 0.21078996360301971, 0.04128681868314743, 0.10882608592510223, -0.0033877140376716852, 0.05348057672381401, 0.04828114062547684, 0.054998479783535004, -0.09321828186511993, 0.0764966830611229, 0.0214554313570261, -0.040644437074661255, -0.030282555148005486, 0.1441122591495514, 0.09831707924604416, -0.02083522453904152, -0.060595668852329254, 0.019780706614255905, -0.08383838832378387, 0.09317674487829208, 0.002781461924314499, -0.09055275470018387, -0.043115030974149704, -0.04331725463271141, -0.0017744784709066153, 0.1034613773226738, -0.030267314985394478, -0.17422306537628174, 0.005850277375429869, -0.021567735821008682, -0.08447394520044327, 0.0423850417137146, -0.12335021048784256, 0.028114739805459976, -0.03881514444947243, -0.028431421145796776, -0.16217902302742004, -0.0126311294734478, 0.09151782840490341, -0.14315128326416016, -0.06146739050745964, 0.015949228778481483, 0.024286454543471336, 0.14437086880207062, -0.070672906935215, -0.1614326536655426, -0.01232293900102377, 0.05642262473702431, -0.08964568376541138, 0.04437476769089699, -0.26295652985572815, -0.10216781497001648, 0.014344091527163982, -0.010366286151111126, -0.021056147292256355, -0.0910845547914505, 0.00871727429330349, -0.0031630571465939283, 0.05958365648984909, 0.03157220035791397, 0.018078306689858437, -0.1832733452320099, -0.006514516193419695, -0.009624889120459557, 0.07311678677797318, -0.09657439589500427, 0.05871707946062088, 0.11353632807731628, -0.06091858446598053, 0.11761844903230667, 0.22051292657852173, 0.03566839173436165, 0.09096818417310715, -0.07522106170654297, 0.1331711709499359, 0.04795970767736435, 0.07560452818870544, 0.040459007024765015, 0.13626454770565033, 0.10130006819963455, 0.06424550712108612, 0.05929917097091675, 0.03278180584311485, 0.015762098133563995, 0.10897156596183777, 0.062043286859989166, -0.06503821909427643, -0.0432242788374424, -0.004247693810611963, -0.009586576372385025, -0.07059884071350098, 0.026063745841383934, -0.06135901063680649, 0.04981975257396698, -0.01252409815788269, 0.024079076945781708, -0.047481976449489594, -0.12498645484447479, -0.06099061295390129, -0.08315032720565796, 0.11513294279575348, -0.07153993099927902, -0.0692986324429512, 0.0757506787776947, -0.06010478362441063, 0.0278424471616745, -0.017780032008886337, -0.00488258246332407, -0.017844803631305695, 0.22984187304973602, -0.07330761849880219, -0.0005993178347125649, 0.286262184381485, -0.0655202567577362, 0.035718951374292374, 0.09429382532835007, -0.0026385898236185312, -0.036393310874700546, 0.10770300775766373, 0.1470898985862732, 0.000873793673235923, 1.3062196082092956e-32, -0.07064671814441681, 0.032574091106653214, -0.03699374571442604, 0.007499945815652609, -0.06911306083202362, -0.039422933012247086, 0.09040798991918564, 0.0824715867638588, -0.15799078345298767, -0.08496502041816711, -0.11025114357471466, 0.0040898933075368404, -0.013645594008266926, 0.08470695465803146, 0.027290046215057373, -0.11909246444702148, 0.09534870833158493, 0.06312309950590134, -0.058382827788591385, -0.09760379046201706, -0.04688093811273575, 0.023945067077875137, -0.07979439198970795, -0.011525739915668964, -0.05911080539226532, 0.008177563548088074, -0.06455092132091522, 0.03357817977666855, 0.0650409385561943, 0.05991823971271515, -0.0724291130900383, 0.12819378077983856, 0.046588122844696045, -0.10161740332841873, -0.114498570561409, 0.009607520885765553, -0.04285634309053421, -0.09296922385692596, 0.0260299239307642, 0.10129149258136749, -0.09115448594093323, 0.19071315228939056, -0.10464920103549957, -0.12622873485088348, 0.08216487616300583, -0.07139842957258224, -0.09040355682373047, 0.05101834610104561, -0.036892883479595184, -0.10661602765321732, -0.010565513744950294, 0.02491619437932968, -0.05042914301156998, 0.0131073622033, -0.030372124165296555, 0.06959908455610275, -0.14102870225906372, -0.10668577998876572, 0.05191678926348686, 0.07153267413377762, 0.0232711099088192, 0.06826068460941315, -0.060254354029893875, 0.06733186542987823, -0.05628746375441551, 0.127939373254776, 0.009678610600531101, -0.032513782382011414, -0.16555427014827728, -0.04631159454584122, -0.006086457055062056, -0.04310186207294464, 0.05850380286574364, 0.006824972108006477, 0.063580222427845, 0.006786484736949205, 0.1080087274312973, 0.14071102440357208, 0.005534122232347727, 0.014334955252707005, 0.0591365247964859, 0.07006127387285233, -0.09775101393461227, 0.06113462522625923, 0.039548005908727646, -0.030993081629276276, -0.01692669466137886, 0.022511187940835953, -0.12663951516151428, -0.027463970705866814, 0.09231151640415192, -0.08357521146535873, -0.0878031775355339, 0.04811132699251175, -0.09282124042510986, -1.1558272283070767e-32, -0.09870577603578568, -0.07377568632364273, -0.009936884976923466, 0.018651263788342476, -0.007626811042428017, 0.16487868130207062, 0.09365497529506683, -0.09515371918678284, 0.08428262919187546, -0.13376717269420624, -0.005405866540968418, 0.09808974713087082, -0.03243756666779518, -0.07381195574998856, -0.07142568379640579, 0.036201175302267075, -0.103488989174366, -0.0694316178560257, -0.04003818705677986, -0.00784714799374342, 0.11624159663915634, 0.2087027132511139, 0.07444386929273605, 0.05661884322762489, 0.04184680059552193, 0.023073825985193253, 0.02500137686729431, 0.0945102721452713, 0.004964819643646479, 0.058792244642972946, -0.12410897761583328, 0.0279983039945364, -0.14462164044380188, 0.019682083278894424, -0.039147667586803436, 0.02664622664451599, -0.06529334932565689, -0.1275559365749359, 0.015674548223614693, -0.04891496151685715, -0.034650299698114395, -0.01340995728969574, 0.005782288499176502, 0.001574894180521369, 0.10459845513105392, -0.025428863242268562, -0.006649950053542852, -0.038610007613897324, 0.15963752567768097, -0.008655828423798084, -0.11221305280923843, 0.029332958161830902, 0.030227744951844215, 0.07336441427469254, -0.10109367221593857, -0.011884545907378197, 0.005252966191619635, -0.06096163019537926, -0.03927087038755417, 0.0023098746314644814, 0.07108083367347717, 0.07824781537055969, -0.035211242735385895, -0.03205642104148865, 0.1372283697128296, 0.14192596077919006, 0.07211341708898544, 0.0339462049305439, 0.02129366807639599, -0.17664919793605804, 0.007813588716089725, -0.07479295134544373, -0.05827115848660469, -0.07323585450649261, 0.0918411985039711, 0.06969684362411499, 0.053174007683992386, -0.06786439567804337, -0.09552008658647537, 0.03525301814079285, -0.03665030747652054, -0.00504785031080246, -0.0008202539174817502, 0.08482276648283005, 0.004828421864658594, 0.06006848067045212, 0.033126723021268845, -0.10470401495695114, -0.04177035763859749, 0.035410281270742416, -0.1233283132314682, -0.10750766098499298, -0.10717687755823135, 0.16167499125003815, 0.037158429622650146, -1.0020607987826224e-07, 0.08391283452510834, -0.0324174202978611, 0.0402626171708107, -0.05702218785881996, -0.017957672476768494, -0.09210657328367233, -0.08127047121524811, 0.026325995102524757, -0.008855026215314865, 0.042020153254270554, -0.007276336196810007, 0.1932750791311264, -0.07586220651865005, 0.014952394179999828, -0.07082812488079071, 0.06542274355888367, -0.023415613919496536, 0.06459888070821762, -0.04361066594719887, -0.12344364821910858, -0.011219395324587822, -0.03115229494869709, 0.10221313685178757, -0.014661298133432865, 0.016013525426387787, 0.014745842665433884, 0.021254098042845726, 0.09583384543657303, 0.009468444623053074, -0.006338194943964481, 0.00959400087594986, -0.0337655134499073, 0.20840699970722198, 0.10906408727169037, 0.020421333611011505, -0.08881478011608124, 0.005469505209475756, 0.14813148975372314, 0.06416155397891998, 0.16814255714416504, -0.01909928396344185, -0.008099919185042381, 0.0076721543446183205, -0.00036323152016848326, -0.03510061651468277, -0.025567810982465744, -0.07761302590370178, -0.03263360261917114, -0.027775725349783897, -0.038576047867536545, -0.012190448120236397, -0.04850253462791443, 0.025755655020475388, 0.05826437100768089, -0.07275599241256714, 0.024800250306725502, -0.05732625350356102, -0.047899048775434494, -0.08544696867465973, 0.041876789182424545, 0.024128802120685577, -0.11243967711925507, 0.0986945852637291, 0.1057848334312439], "changes": {"1wk": 6.651379533131571, "1mo": 6.651379533131571}}, {"text": "Even after rising 13% this past week, Clearside Biomedical (NASDAQ:CLSD) shareholders are still down 77% over the past three years editorial-team@simplywallst.com (Simply Wall St) Sun, Nov 10, 2024, 3:40 PM 3 min read In This Article: CLSD It's nice to see the Clearside Biomedical, Inc. ( NASDAQ:CLSD ) share price up 13% in a week. But that doesn't change the fact that the returns over the last three years have been stomach churning. In that time the share price has melted like a snowball in the desert, down 77%. So it's about time shareholders saw some gains. Only time will tell if the company can sustain the turnaround. On a more encouraging note the company has added US$9.7m to its market cap in just the last 7 days, so let's see if we can determine what's driven the three-year loss for shareholders. See our latest analysis for Clearside Biomedical Clearside Biomedical isn't currently profitable, so most analysts would look to revenue growth to get an idea of how fast the underlying business is growing. Generally speaking, companies without profits are expected to grow revenue every year, and at a good clip. As you can imagine, fast revenue growth, when maintained, often leads to fast profit growth. In the last three years Clearside Biomedical saw its revenue shrink by 38% per year. That's definitely a weaker result than most pre-profit companies report. And as you might expect the share price has been weak too, dropping at a rate of 21% per year. Never forget that loss making companies with falling revenue can and do cause losses for everyday investors. There is a good reason that investors often describe buying a sharply falling stock price as 'trying to catch a falling knife'. Think about it. You can see below how earnings and revenue have changed over time (discover the exact values by clicking on the image). NasdaqGM:CLSD Earnings and Revenue Growth November 10th 2024 We like that insiders have been buying shares in the last twelve months. Even so, future earnings will be far more important to whether current shareholders make money. So we recommend checking out this free report showing consensus forecasts A Different Perspective Clearside Biomedical shareholders gained a total return of 18% during the year. Unfortunately this falls short of the market return. The silver lining is that the gain was actually better than the average annual return of 2% per year over five year. This could indicate that the company is winning over new investors, as it pursues its strategy. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Consider for instance, the ever-present spectre of investment risk. We've identified 6 warning signs with Clearside Biomedical (at least 2 which are concerning) , and understanding them should be part of your investment process. Story Continues If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: most of them are flying under the radar). Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "CLSD", "date": "2024-11-10T15:40:01", "sentiment": {"score": -0.9316378273069859, "confidence": 0.9487318396568298, "probabilities": {"positive": 0.01709401234984398, "negative": 0.9487318396568298, "neutral": 0.03417418524622917}}, "embedding": [-0.037202298641204834, -0.08239597082138062, 0.10592971742153168, -0.03405865654349327, -0.0012605544179677963, -0.07447454333305359, -0.012429090216755867, 0.1023201197385788, 0.12068062275648117, 0.07349887490272522, -0.07043977826833725, 0.07686168700456619, -0.07530459761619568, -0.02648591436445713, -0.06838029623031616, -0.059224240481853485, -0.05519527196884155, 0.03430893272161484, -0.08175209164619446, 0.11256939172744751, -0.11737591028213501, -0.019852198660373688, 0.023546352982521057, 0.06127167493104935, -0.007989801466464996, 0.019227182492613792, -0.006680253893136978, -0.058926772326231, -0.080984927713871, -0.05086742341518402, -0.049704618752002716, 0.08958248794078827, 0.10415099561214447, 0.02074275352060795, -0.04619898647069931, 0.023160267621278763, -0.0139676034450531, 0.07044176757335663, 0.07609235495328903, 0.0752171203494072, -0.0520445853471756, 0.006835252046585083, -0.054048437625169754, -0.00995616801083088, -0.02727031148970127, -0.15117672085762024, 0.03090912662446499, -0.029555264860391617, 0.08198049664497375, 0.056077565997838974, -0.11642538011074066, -0.06480897963047028, 0.04819466173648834, 0.0032541670370846987, -0.052761487662792206, 0.006231432314962149, -0.1427716314792633, -0.06891427934169769, -0.014504743739962578, -0.0004812190309166908, 0.03570941463112831, 0.004625337198376656, 0.05656665191054344, -0.016582651063799858, 0.1634640246629715, 0.01860804855823517, 0.03511959686875343, -0.02847129851579666, -0.09928309917449951, 0.05508516728878021, 0.1172063946723938, -0.03147755190730095, -0.030853386968374252, 0.003989230375736952, -0.12117920815944672, 0.1565154492855072, 0.1418498009443283, 0.10900597274303436, 0.10694000124931335, -0.05302524194121361, 0.10161417722702026, 0.05025644972920418, -0.09858279675245285, -0.054026730358600616, -0.03420347347855568, 0.04305815324187279, 0.18203586339950562, 0.03459324687719345, -0.02607540786266327, -0.01705889403820038, 0.08500314503908157, 0.0052604516968131065, -0.007947592064738274, -0.021229811012744904, 0.041925638914108276, 0.08183659613132477, -0.09499174356460571, -0.06506437808275223, 0.01815149560570717, 0.05804365873336792, 0.06826493889093399, 0.23209331929683685, -0.05439823120832443, -0.1489221453666687, -0.03821916505694389, -0.09643034636974335, 0.042362429201602936, 0.018203381448984146, -0.04511544853448868, 0.05442472919821739, 0.007329647429287434, 0.13516241312026978, -0.08177297562360764, -0.0007748077623546124, -0.01418971922248602, 0.10541650652885437, -0.0411730632185936, -0.06775885075330734, 0.026633543893694878, 0.0602068230509758, 0.027519360184669495, 0.11544831097126007, -0.015428243204951286, -0.012385688722133636, -0.015596244484186172, 0.0885905772447586, -0.04063110426068306, 1.2992526001287657e-32, -0.010027109645307064, -0.0127937700599432, 0.0384301133453846, -0.09257189184427261, -0.09926773607730865, -0.06638910621404648, -0.013920692726969719, -0.029908165335655212, -0.06737998127937317, -0.05482242628931999, -0.11935357749462128, 0.006008602678775787, 0.010778985917568207, -0.08560309559106827, 0.043272919952869415, -0.11207360029220581, -0.01415444165468216, -0.020125307142734528, 0.0278322771191597, -0.1179838478565216, -0.06486780196428299, 0.020898470655083656, -0.03400975465774536, 0.008923271670937538, 0.026139894500374794, -0.06748373806476593, -0.12385906279087067, 0.03649989888072014, 0.04110052436590195, 0.042889371514320374, 0.0046957312151789665, 0.015042910352349281, 0.013044657185673714, -0.12321023643016815, -0.058766819536685944, -0.05276710167527199, -0.0441175177693367, 0.03278805688023567, 0.08072888106107712, 0.04932881146669388, -0.10801144689321518, 0.05841425061225891, -0.13166359066963196, -0.060420773923397064, -0.0017139390110969543, -0.036357514560222626, -0.04423152655363083, -0.024765830487012863, -0.0877172127366066, -0.029591411352157593, -0.025619709864258766, 0.023541148751974106, -0.0031038280576467514, -0.035434991121292114, 0.00928749330341816, 0.07300155609846115, 0.003961635287851095, -0.16448834538459778, 0.00082364771515131, 0.12697963416576385, 0.14099371433258057, 0.14577336609363556, -0.01952895149588585, 0.04345740005373955, -0.2139175832271576, 0.137494295835495, 0.05335497111082077, 0.0596897155046463, -0.11259525269269943, 0.09240885823965073, 0.028933944180607796, -0.031209897249937057, -0.030479520559310913, -0.10777352750301361, 0.10450941324234009, -0.06007782369852066, 0.0005053170025348663, -0.009686430916190147, 0.05855192244052887, 0.03346073627471924, 0.10173729062080383, 0.010502338409423828, 0.08500178158283234, -0.049618199467659, -0.026982970535755157, -0.015897484496235847, 0.07530628889799118, 0.020451568067073822, -0.11247026920318604, -0.03802165389060974, -0.011715189553797245, -0.030847564339637756, -0.013715427368879318, 0.15963603556156158, -0.013751341961324215, -1.1475982535725422e-32, -0.04184897616505623, -0.01374219823628664, -0.0376482717692852, -0.053261131048202515, -0.04258592426776886, -0.05181808024644852, 0.06537668406963348, 0.04450943320989609, -0.14433227479457855, -0.0945025235414505, -0.019225046038627625, 0.06952651590108871, -0.08297568559646606, 0.04448442906141281, -0.06830620765686035, 0.013771338388323784, 0.13666391372680664, -0.08789055049419403, -0.04880315437912941, -0.0881330817937851, 0.0022325967438519, 0.1910918951034546, -0.09225407987833023, 0.07028993219137192, -0.006338948383927345, 0.11647840589284897, -0.025513093918561935, 0.19424879550933838, 0.030430737882852554, -0.08243843913078308, -0.09565383195877075, 0.035666417330503464, -0.07259675115346909, 0.039448220282793045, 0.043845489621162415, 0.016806576400995255, -0.04544883593916893, -0.1586741805076599, -0.013296986930072308, -0.03910357505083084, 0.07758636772632599, 0.0691603273153305, 0.027632448822259903, -0.0027594384737312794, 0.11269888281822205, 0.026931146159768105, 0.03467248007655144, 0.04110393300652504, 0.15080015361309052, 0.150226891040802, 0.01726163551211357, -0.036003608256578445, 0.04840961471199989, 0.12412159144878387, -0.06090749800205231, 0.12574400007724762, -0.06560256332159042, -0.0630311369895935, -0.0765780657529831, 0.050508417189121246, -0.03036373481154442, 0.044728055596351624, -0.03733205422759056, 0.06027175486087799, 0.026439618319272995, -0.019937219098210335, -0.013577034696936607, -0.04234452173113823, -0.036800503730773926, -0.0950944647192955, 0.019928772002458572, -0.06113435700535774, -0.06449427455663681, -0.10618777573108673, -0.013006050139665604, 0.22605502605438232, -0.10050566494464874, -0.08141602575778961, -0.035759516060352325, 0.0587463453412056, -0.010592786595225334, 0.02033071219921112, 0.027856793254613876, 0.0785595178604126, -0.10839948803186417, 0.07741938531398773, -0.058412693440914154, -0.1064332127571106, -0.05220393091440201, 0.0566379651427269, -0.05278322100639343, -0.23848357796669006, -0.10667730867862701, 0.061197422444820404, -0.0072815995663404465, -9.975184411814553e-08, 0.08917126059532166, -0.10198040306568146, 0.03950382024049759, 0.018029270693659782, 0.1216684877872467, -0.10639679431915283, 0.0687040239572525, 0.007118149660527706, 0.087270587682724, 0.08003292232751846, 0.0558198057115078, 0.03877725079655647, -0.12631982564926147, 0.09720531851053238, -0.10419946908950806, 0.057040102779865265, -0.1258469969034195, 0.030359217897057533, -0.033394865691661835, -0.19672763347625732, -0.03163384273648262, 0.01075112633407116, 0.15961922705173492, 0.0738525390625, 0.011210141703486443, 0.02127091959118843, -0.048916056752204895, 0.057806506752967834, -0.041963204741477966, -0.019898610189557076, 0.06802934408187866, -0.024127032607793808, 0.15898674726486206, 0.052772119641304016, -0.0019848535303026438, -0.0011300481855869293, 0.07864779978990555, 0.044664010405540466, 0.05964675173163414, 0.16721229255199432, -0.020661091431975365, 0.05252532288432121, 0.008256066590547562, -0.04460560530424118, -0.04126812517642975, -0.07348242402076721, -0.07604527473449707, 0.18266892433166504, 0.07298021763563156, -0.18372276425361633, 0.1255728304386139, -0.09674318134784698, 0.0003629205748438835, 0.10845071077346802, 0.04823360964655876, -0.03279699385166168, -0.17281119525432587, 0.02777012065052986, -0.17838412523269653, 0.029996059834957123, -0.046781037002801895, -0.14979860186576843, 0.0411919541656971, 0.1708468198776245], "changes": {"1wk": -9.174313832990853, "1mo": -6.422022964083117}}, {"text": "All You Need to Know About Clearside Biomedical (CLSD) Rating Upgrade to Buy Zacks Equity Research Fri, Nov 15, 2024, 8:00 PM 3 min read In This Article: CLSD Investors might want to bet on Clearside Biomedical, Inc. (CLSD), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change. A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years. The power of a changing earnings picture in determining near-term stock price movements makes the Zacks rating system highly useful for individual investors, since it can be difficult to make decisions based on rating upgrades by Wall Street analysts. These are mostly driven by subjective factors that are hard to see and measure in real time. As such, the Zacks rating upgrade for Clearside Biomedical is essentially a positive comment on its earnings outlook that could have a favorable impact on its stock price. Most Powerful Force Impacting Stock Prices The change in a company's future earnings potential, as reflected in earnings estimate revisions, and the near-term price movement of its stock are proven to be strongly correlated. That's partly because of the influence of institutional investors that use earnings and earnings estimates for calculating the fair value of a company's shares. An increase or decrease in earnings estimates in their valuation models simply results in higher or lower fair value for a stock, and institutional investors typically buy or sell it. Their bulk investment action then leads to price movement for the stock. For Clearside Biomedical, rising earnings estimates and the consequent rating upgrade fundamentally mean an improvement in the company's underlying business. And investors' appreciation of this improving business trend should push the stock higher. Harnessing the Power of Earnings Estimate Revisions As empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock movements, tracking such revisions for making an investment decision could be truly rewarding. Here is where the tried-and-tested Zacks Rank stock-rating system plays an important role, as it effectively harnesses the power of earnings estimate revisions. The Zacks Rank stock-rating system, which uses four factors related to earnings estimates to classify stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record, with Zacks Rank #1 stocks generating an average annual return of +25% since 1988. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here >>>>. Story Continues Earnings Estimate Revisions for Clearside Biomedical For the fiscal year ending December 2024, this company is expected to earn -$0.52 per share, which is a change of 1.9% from the year-ago reported number. Analysts have been steadily raising their estimates for Clearside Biomedical. Over the past three months, the Zacks Consensus Estimate for the company has increased 6.6%. Bottom Line Unlike the overly optimistic Wall Street analysts whose rating systems tend to be weighted toward favorable recommendations, the Zacks rating system maintains an equal proportion of 'buy' and 'sell' ratings for its entire universe of more than 4000 stocks at any point in time. Irrespective of market conditions, only the top 5% of the Zacks-covered stocks get a 'Strong Buy' rating and the next 15% get a 'Buy' rating. So, the placement of a stock in the top 20% of the Zacks-covered stocks indicates its superior earnings estimate revision feature, making it a solid candidate for producing market-beating returns in the near term. You can learn more about the Zacks Rank here >>> The upgrade of Clearside Biomedical to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the near term. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Clearside Biomedical, Inc. (CLSD) : Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "CLSD", "date": "2024-11-15T20:00:11", "sentiment": {"score": 0.1262451484799385, "confidence": 0.1557450294494629, "probabilities": {"positive": 0.1557450294494629, "negative": 0.029499880969524384, "neutral": 0.8147551417350769}}, "embedding": [-0.12187129259109497, -0.07006770372390747, 0.027760419994592667, 0.0008109258487820625, 0.030671317130327225, -0.033613238483667374, -0.05508352071046829, 0.03607645630836487, 0.18848377466201782, 0.06948982924222946, -0.08805747330188751, 0.1077871322631836, 0.01821664720773697, -0.01740904524922371, -0.0999622642993927, -0.0007892278954386711, 0.09621880203485489, 0.029771938920021057, -0.1365157514810562, 0.052788034081459045, -0.044887229800224304, -0.02897639200091362, 0.1099262535572052, -0.008773542940616608, -0.031016530469059944, -0.04678083211183548, -0.03786826878786087, 0.0722368136048317, -0.07539060711860657, -0.10570257157087326, -0.11916932463645935, 0.09123165905475616, 0.13401859998703003, -0.04144185036420822, -0.1843167543411255, -0.057524148374795914, 0.019345484673976898, 0.07882526516914368, 0.1362212896347046, 0.07887627929449081, -0.06442765146493912, 0.07273046672344208, -0.0812283456325531, -0.0543731264770031, -0.06661809980869293, -0.16995316743850708, 0.02566738985478878, -0.07622754573822021, -0.05391218885779381, -0.017176080495119095, -0.11056143045425415, -0.10020759701728821, 0.05588884651660919, -0.01497900951653719, -0.16102096438407898, 0.05915147438645363, -0.10119668394327164, -0.074411541223526, 0.030149243772029877, 0.014229176566004753, -0.04361223429441452, 0.05288242548704147, 0.009402715601027012, 0.04550410062074661, 0.1710359752178192, -0.021404948085546494, -0.010939421132206917, 0.036543138325214386, -0.10334280133247375, -0.027872027829289436, 0.052474915981292725, -0.03812672942876816, -0.011825446970760822, -0.023289117962121964, -0.07177989929914474, 0.07969418168067932, 0.08122481405735016, 0.14392544329166412, 0.129163458943367, -0.11250240355730057, 0.011570440605282784, -0.0697314664721489, 0.026745371520519257, -0.03442958742380142, 0.06852675974369049, -0.007714347913861275, 0.10460394620895386, -0.009782131761312485, -0.04130871593952179, 0.09873563796281815, 0.1100543886423111, -0.08843401074409485, -0.020165376365184784, -0.039181433618068695, 0.030082285404205322, 0.013519477099180222, -0.1277773678302765, 0.0010520154610276222, 0.025604113936424255, 0.0545029416680336, 0.008649074472486973, 0.11479446291923523, -0.0857774019241333, 0.007520980667322874, 0.03235370293259621, -0.05543874204158783, 0.14177313446998596, 0.00942777656018734, -0.008982895873486996, -0.011265651322901249, 0.011757615953683853, 0.07969076186418533, -0.05996864289045334, -0.00855417549610138, -0.05657169967889786, 0.0641804188489914, 0.008520936593413353, 0.06509913504123688, 0.137135848402977, 0.026283003389835358, 0.12106440961360931, -0.021861139684915543, 0.008971883915364742, -0.0698348879814148, -0.06833766400814056, 0.17656829953193665, -0.05207308381795883, 9.390448376487352e-33, 0.030794255435466766, 0.056179843842983246, 0.005285889841616154, -0.05698077008128166, -0.059150055050849915, -0.049782272428274155, -0.04628880321979523, -0.07084062695503235, 0.00018827023450285196, -0.060794271528720856, -0.054440464824438095, 0.1996576488018036, -0.0021970749367028475, 0.005573059432208538, 0.07331561297178268, -0.03970000520348549, -0.03186808153986931, 0.06188255548477173, 0.01854042336344719, -0.03602277487516403, 0.05008593946695328, -0.02299216389656067, -0.02545708790421486, -0.11323975026607513, -0.010296573862433434, -0.04660854488611221, -0.07988622039556503, 0.05592455714941025, -0.12058097124099731, 0.04112900048494339, 0.020390933379530907, 0.0446154810488224, 0.019098250195384026, -0.09468238800764084, -0.0708986222743988, -0.02560591697692871, 0.03861527144908905, -0.06377092748880386, 0.112312451004982, 0.019233858212828636, 0.0032875696197152138, 0.01729555055499077, -0.2549058198928833, -0.07601381093263626, -0.004117421805858612, 0.036517538130283356, -0.12498664110898972, 0.029698871076107025, -0.04950534179806709, -0.013098428025841713, -0.03248606249690056, 0.013226800598204136, 0.0011625939514487982, -0.06182002276182175, -0.10549809783697128, 0.022996455430984497, 0.04892557114362717, -0.2158437818288803, -0.06532767415046692, 0.04621284827589989, 0.06646284461021423, 0.17926980555057526, 0.0037332382053136826, -0.11137630045413971, -0.10645641386508942, 0.14483574032783508, -0.018211621791124344, 0.07947299629449844, -0.06982618570327759, 0.08928819745779037, -0.028572237119078636, 0.07318130135536194, 0.03613477572798729, -0.07571528106927872, 0.0957648828625679, -0.07861839234828949, -0.1209726482629776, 0.021135549992322922, 0.063695028424263, 0.03006342425942421, 0.0476134791970253, -0.008876040577888489, -0.007935062050819397, -0.07429426908493042, 0.0701482743024826, -0.014242591336369514, -0.012166798114776611, 0.08430711179971695, -0.01838657259941101, -0.06267135590314865, 0.07816807925701141, -0.045553889125585556, -0.04509919881820679, 0.141415536403656, -0.029827244579792023, -9.617369479389933e-33, -0.16488811373710632, -0.004172654822468758, -0.0650818720459938, 0.05686322599649429, -0.030725471675395966, -0.03478187322616577, -0.00614864332601428, 0.019645750522613525, -0.00847553089261055, -0.1359388381242752, -0.04135163128376007, 0.05330463498830795, -0.1059979572892189, -0.03244863077998161, 0.05067647621035576, -0.018914315849542618, -0.1123732477426529, -0.09062828123569489, -0.04928365349769592, -0.07270607352256775, 0.09962641447782516, 0.15955275297164917, -0.01764196716248989, 0.11709623038768768, 0.06250020116567612, 0.027143515646457672, -0.06043607369065285, 0.21256881952285767, 0.13518299162387848, -0.05017569661140442, 0.049348022788763046, 0.025976160541176796, -0.05384386330842972, 0.09208504110574722, -0.0019424562342464924, -0.007520873099565506, 0.07152225077152252, -0.1948958784341812, 0.008893460035324097, 0.0775599405169487, 0.03958657383918762, 0.0005982024595141411, 0.0026685334742069244, -0.041257329285144806, 0.0719853937625885, 0.062466397881507874, 0.0057538943365216255, 0.058350034058094025, 0.08671382814645767, -0.042721472680568695, 0.06660500913858414, 0.09375296533107758, 0.006556559354066849, 0.1772007942199707, -0.13279485702514648, 0.022397764027118683, -0.09718485176563263, 0.013518811203539371, -0.05223258584737778, 0.05938974395394325, 0.02229742519557476, 0.14518573880195618, -0.04098208248615265, 0.0954117551445961, 0.02872900478541851, -0.02628486417233944, 0.030543982982635498, -0.055076055228710175, -0.08916741609573364, 0.0280801672488451, -0.05408250913023949, -0.1094510406255722, 0.07949323952198029, -0.05681251734495163, -0.013999721966683865, 0.1257084608078003, 0.01659313589334488, -0.19650804996490479, -0.1354568898677826, -0.001068083569407463, -0.05026416480541229, 0.015968766063451767, 0.042120419442653656, -0.06046400964260101, -0.08414650708436966, 0.0935826301574707, 0.010050369426608086, -0.010185016319155693, -0.028457824140787125, -0.07084083557128906, -0.044425055384635925, -0.2461894154548645, -0.15918944776058197, -0.030893629416823387, -0.0556432381272316, -1.0004168871091679e-07, 0.05662534385919571, -0.11665110290050507, -0.03634537383913994, 0.07141867280006409, 0.03423827514052391, -0.041977204382419586, -0.05624653398990631, -0.04395022988319397, 0.07984902709722519, 0.031175201758742332, 0.11391967535018921, 0.12408754974603653, -0.1360124945640564, -0.0006537851877510548, -0.008071630261838436, 0.035993169993162155, -0.02552184648811817, 0.07351911067962646, 0.02227887511253357, -0.1257978081703186, -0.04463684558868408, -0.0008718222379684448, 0.11221785843372345, -0.012804364785552025, 0.1223444789648056, -0.022011438384652138, -0.08513042330741882, -0.017965033650398254, 0.031435608863830566, 0.03513147309422493, 0.12703442573547363, 0.006700439378619194, 0.16649854183197021, 0.1352161020040512, 0.11752155423164368, 0.038366470485925674, 0.0995538979768753, 0.051757827401161194, 0.008368492126464844, 0.19353026151657104, 0.06739364564418793, 0.009562903083860874, -0.12629057466983795, 0.035322267562150955, 0.016839567571878433, -0.05644885450601578, -0.09867662191390991, 0.10747319459915161, 0.007690392434597015, -0.13608574867248535, 0.10783685743808746, -0.08366400003433228, 0.0066775367595255375, 0.048629291355609894, -0.01861283928155899, 0.02707427181303501, -0.13177721202373505, -0.010642883367836475, -0.09712499380111694, 0.030151057988405228, 0.12981869280338287, -0.08353213965892792, 0.05702568218111992, 0.08680431544780731], "changes": {"1wk": 9.090912374911527, "1mo": 3.0303001111897543}}, {"text": "Clearside Biomedical Inc (CLSD) Q3 2024 Earnings Call Highlights: Promising Clinical Trial ... GuruFocus News Wed, Nov 13, 2024, 10:17 AM 3 min read In This Article: CLSD Release Date: November 12, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript . Positive Points Clearside Biomedical Inc ( NASDAQ:CLSD ) reported positive results from the Odyssey phase two B clinical trial for wet AMD, demonstrating potential efficacy and safety of CLS AX. The company is the only TKI Wet AMD program with repeat dosing data, providing a competitive advantage as they advance CLS AX into phase three. Clearside's SCS microinjector has been successfully used in over 10,000 injections, showcasing its safety and reliability. The company has solidified its formulation expertise and has commercial scale microinjector manufacturing capability with ISO certification. Clearside's collaboration with Arctic Vision and Santan Pharmaceuticals highlights strategic validation of their super choroidal delivery platform. Negative Points Clearside Biomedical Inc ( NASDAQ:CLSD ) has cash and cash equivalents totaling $23.6 million, which is only sufficient to fund operations into the third quarter of 2025. The company is still in the planning stages for the phase three trial of CLS AX, with details such as cost and design yet to be finalized. There is uncertainty regarding the FDA's acceptance of flexible dosing for CLS AX, which is crucial for its adoption in the wet AMD market. The geographic atrophy program is still in early stages, with no clear timeline for IND submission. Clearside faces competition in the TKI space, and the success of their flexible dosing strategy remains to be seen. Q & A Highlights Warning! GuruFocus has detected 3 Warning Signs with CLSD. Q : Can you provide feedback from the AAO meeting regarding the study design that incorporated retreatment rather than supplemental rescue with aflibercept, and the 3 to 6 months flexibility you're looking for on your label? A : The feedback from the AAO meeting was very positive. Attendees appreciated the flexibility offered by our approach, which is a key differentiator. The retreatment design was well-received, and the flexibility aligns with physician needs for varying treatment schedules. (George Lake, CEO; Dr. Victor Chang, Chief Medical Officer) Q : Are there any concerns about the FDA's view on redosing CLSAX within six months? A : We have no concerns from the FDA's perspective. Our Phase 2 study already demonstrated the safety of redosing within six months, and we have data supporting multiple redosing. (Dr. Victor Chang, Chief Medical Officer) Q : Can you provide more details on the Phase 3 trial design for CLSAX and the geographic atrophy program? A : The Phase 3 trial will likely follow a non-inferiority design with flexible dosing, similar to aflibercept's high-dose design. For geographic atrophy, we're exploring small molecules targeting choroidal perfusion and inflammation, with plans to advance candidates toward an IND application. (Dr. Victor Chang, Chief Medical Officer) Story Continues Q : Will you be sharing additional data analysis from the Odyssey trial? A : Yes, we plan to present more data at upcoming medical conferences, including the Asia Pacific Visual Retinal Society meeting and the Flu Retina meeting in Europe. The data will clarify areas of confusion and provide additional analysis. (Dr. Victor Chang, Chief Medical Officer) Q : Do you have an estimated cost for the Phase 3 program for the wet AMD asset? A : We are still working on finalizing the trial design, which will determine the cost. Details will be available once the design is finalized and after our end-of-phase 2 meeting. (George Lake, CEO) For the complete transcript of the earnings call, please refer to the full earnings call transcript . This article first appeared on GuruFocus . View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "CLSD", "date": "2024-11-13T10:17:21", "sentiment": {"score": 0.6699285786598921, "confidence": 0.6826915740966797, "probabilities": {"positive": 0.6826915740966797, "negative": 0.012762995436787605, "neutral": 0.30454543232917786}}, "embedding": [-0.10164393484592438, -0.06817875057458878, 0.0049921851605176926, -0.09314288198947906, -0.041913263499736786, -0.09754054248332977, 0.05751493200659752, 0.1486228108406067, 0.09323668479919434, 0.07077717036008835, 0.02609766274690628, 0.008060970343649387, 0.04850282892584801, 0.09164996445178986, -0.07051090896129608, 0.0452420711517334, 0.06410729885101318, 0.001882440410554409, -0.02107010781764984, 0.13328701257705688, 0.06620410084724426, 0.02169671095907688, -0.004751202650368214, 0.0578758530318737, -0.12486118078231812, -0.017170531675219536, -0.04756878316402435, -0.016721971333026886, -0.05338302254676819, -0.09125487506389618, -0.015212273225188255, 0.16004830598831177, 0.01955379545688629, -0.1593397557735443, 0.03146279975771904, 0.029894277453422546, -0.0962461531162262, 0.05342215299606323, -0.0831315815448761, 0.002900604158639908, -0.0007122624665498734, -0.020126894116401672, -0.015428885817527771, -0.02239527553319931, 0.02273431047797203, -0.1052364856004715, -0.0959184318780899, -0.05392415449023247, -0.026732975617051125, 0.09360745549201965, 0.022090138867497444, -0.14964289963245392, 0.05740445852279663, 0.08843204379081726, -0.11337533593177795, 0.02351963147521019, -0.21641448140144348, -0.10086396336555481, -0.12732750177383423, -0.03427603095769882, -0.025917772203683853, -0.032444484531879425, 0.007124759256839752, 0.041697073727846146, 0.15724463760852814, 0.09683957695960999, -0.10554058849811554, -0.16218483448028564, -0.01860973984003067, -0.05395995080471039, 0.04641091823577881, -0.10545709729194641, 0.021247703582048416, -0.0023490022867918015, 0.00971134938299656, 0.1979074478149414, 0.20957979559898376, 0.14462190866470337, 0.042686816304922104, -0.08508600294589996, 0.08841901272535324, 0.04647696018218994, 0.01869816705584526, -0.003224278101697564, 0.010241899639368057, 0.0625946968793869, 0.07337663322687149, 0.10520361363887787, -0.04988870769739151, -0.01838035136461258, 0.19403094053268433, 0.0264742411673069, -0.04180591180920601, -0.03397177904844284, 0.032567281275987625, -0.03354743495583534, -0.10382970422506332, 0.019349515438079834, 0.016641758382320404, 0.011717361398041248, 0.042914018034935, 0.09118756651878357, -0.16821420192718506, -0.12706294655799866, -0.05741604417562485, -0.09861986339092255, 0.08650925755500793, -0.09071294963359833, -0.036504052579402924, 0.0024575130082666874, -0.042014095932245255, 0.04816337302327156, 0.0933331549167633, -0.017841927707195282, -0.006250510457903147, 0.20502591133117676, -0.08212744444608688, 0.10340776294469833, 0.28304460644721985, -0.07763103395700455, 0.018899451941251755, -0.018818732351064682, -0.05874495953321457, -0.043303243815898895, 0.0772046148777008, 0.16722656786441803, 0.021901419386267662, 1.2001601161275762e-32, -0.044620878994464874, -0.003148583695292473, 0.03436378389596939, -0.03839321434497833, -0.06735087186098099, -0.04225502908229828, 0.08640094101428986, -0.03940894454717636, -0.09107687324285507, -0.08446840941905975, -0.1256243884563446, 0.06612829864025116, -0.03451975807547569, 0.021292677149176598, -0.003385119140148163, -0.11773492395877838, 0.032144978642463684, 0.052815258502960205, -0.09240102767944336, 0.005229656584560871, 0.03046111762523651, -0.00518818199634552, -0.06949939578771591, -0.011778942309319973, 0.03569168224930763, 0.024091042578220367, -0.09186917543411255, 0.057803913950920105, 0.05001894757151604, 0.06799763441085815, -0.16724559664726257, 0.06522156298160553, 0.019421949982643127, -0.11218030750751495, -0.10781653970479965, 0.08431845158338547, -0.12023940682411194, -0.0817718505859375, 0.001384565606713295, 0.03580911457538605, -0.02491419017314911, 0.1403009295463562, -0.0970427393913269, -0.13328619301319122, 0.06858956813812256, -0.06507734209299088, -0.07522536814212799, 0.02637256495654583, 0.023626968264579773, -0.09428705275058746, -0.0401134230196476, 0.07372505217790604, -0.032409023493528366, -0.07070364058017731, 0.02836121991276741, 0.012630834244191647, -0.08294855803251266, -0.11163202673196793, -0.029156126081943512, 0.19293853640556335, 0.04315658658742905, 0.05886203050613403, -0.10460896044969559, -0.005488431081175804, -0.11971595138311386, 0.16937172412872314, -0.02747565507888794, -0.07761740684509277, -0.05276273563504219, 0.016119860112667084, -0.05746808648109436, 0.006030610762536526, 0.08223225921392441, 0.006255908869206905, 0.05777927488088608, -0.07870172709226608, 0.129891037940979, 0.07237236201763153, -0.014156184159219265, -0.05008051544427872, 0.037580471485853195, 0.08529405295848846, -0.10890515148639679, 0.10380871593952179, 0.03417062759399414, -0.07196441292762756, -0.0004312177188694477, 0.03888585418462753, -0.12554706633090973, -0.036470696330070496, 0.053525909781455994, -0.043765559792518616, 0.00771226454526186, 0.14041763544082642, -0.09415487200021744, -1.0197999036506847e-32, -0.09117218106985092, -0.03958994522690773, -0.032165657728910446, -0.0016090944409370422, 0.0073981210589408875, 0.10840317606925964, 0.13408143818378448, -0.012578954920172691, 0.030108410865068436, -0.11474047601222992, -0.022701933979988098, 0.11369135975837708, -0.09298825263977051, -0.06272542476654053, -0.0759725570678711, 0.07436161488294601, -0.08746403455734253, -0.10178794711828232, -0.01954665593802929, 0.0024778489023447037, 0.21869564056396484, 0.25361472368240356, 0.0698338970541954, 0.06453457474708557, 0.0766628086566925, 0.07893560826778412, -0.029467269778251648, 0.166269451379776, 0.044778577983379364, -0.031839534640312195, -0.07950557768344879, -0.011827056296169758, -0.12271939218044281, 0.04219547659158707, -0.008770403452217579, -0.039419788867235184, 0.035241518169641495, -0.09712092578411102, 0.013641576282680035, -0.022451940923929214, 0.032280515879392624, -0.0027343144174665213, -0.09478897601366043, 0.04663954675197601, 0.060146771371364594, 0.009880912490189075, -0.0020783059298992157, -0.06233254447579384, 0.13341546058654785, 0.0068553751334548, -0.1478641778230667, -0.00965830311179161, 0.019813911989331245, 0.07628905773162842, -0.03737751767039299, -0.0022965557873249054, -0.01233934611082077, -0.0823557898402214, -0.07807193696498871, -0.03767923265695572, -0.026790495961904526, 0.12727023661136627, -0.02476630173623562, -0.02407664991915226, 0.11613567173480988, 0.10091812908649445, 0.10520794987678528, 0.004929423797875643, -0.12814585864543915, -0.09536326676607132, -0.0741056501865387, -0.02450987882912159, 0.011236967518925667, -0.08589430153369904, 0.12393511086702347, 0.0981941968202591, -0.024925563484430313, -0.1840774118900299, -0.11355078220367432, 0.006504993420094252, -0.1214258074760437, 0.02736719697713852, -0.00492059625685215, 0.11672420054674149, 0.08864583820104599, 0.13126349449157715, 0.02193506434559822, -0.1301650106906891, -0.04909016191959381, 0.10672516375780106, -0.052696093916893005, -0.06042597070336342, 0.02952083945274353, 0.14697180688381195, 0.01929696649312973, -9.993125615892495e-08, 0.13720905780792236, -0.02651626244187355, 0.019698837772011757, -0.030998632311820984, -0.052607569843530655, -0.09012162685394287, -0.05327293276786804, 0.031502507627010345, -0.06664230674505234, 0.0777774229645729, 0.017011644318699837, 0.12808072566986084, -0.08020250499248505, 0.03208598494529724, -0.033425115048885345, 0.08675233274698257, -0.020744478330016136, 0.01146584190428257, -0.07614022493362427, -0.20535698533058167, -0.10725267231464386, -0.022199023514986038, 0.05480584129691124, -0.005946269258856773, 0.04097452759742737, 0.03815199434757233, 0.004421309567987919, 0.13783708214759827, 0.05143008381128311, -0.05571090802550316, 0.0494270995259285, -0.0742294043302536, 0.15414541959762573, 0.13543106615543365, 0.02811574935913086, -0.05184674263000488, -0.012399988248944283, 0.13585273921489716, 0.048875510692596436, 0.24960875511169434, -0.02111603505909443, 0.04083601385354996, 0.027186457067728043, -0.005477165337651968, 0.035702936351299286, -0.05111587047576904, -0.17883720993995667, -0.05096430331468582, -0.04663294181227684, 0.015268953517079353, -0.0038771694526076317, -0.11456134915351868, -0.008704984560608864, 0.10924078524112701, 0.010364669375121593, 0.05913219228386879, -0.0895291417837143, -0.052179574966430664, 0.002762766554951668, 0.06580109894275665, 0.028620269149541855, -0.14281928539276123, 0.05613365024328232, 0.08092311769723892], "changes": {"1wk": -4.629636068402729, "1mo": -7.407411086706321}}]